Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Tofacitinib | hsa00010 | Glycolysis / Gluconeogenesis | 1.89E-03 | 5 | P04075, P14550, P11766, P07195, P60174 | ALDOA, AKR1A1, ADH5, LDHB, TPI1 | More | | Tofacitinib | hsa00020 | Citrate cycle (TCA cycle) | 3.41E-02 | 2 | P50213, O14521 | IDH3A, SDHD | More | | Tofacitinib | hsa00030 | Pentose phosphate pathway | 1.80E-09 | 4 | P60891, P51854, P52209, P37837 | PRPS1, TKTL1, PGD, TALDO1 | More | | Tofacitinib | hsa00040 | Pentose and glucuronate interconversions | 3.53E-02 | 1 | O60701 | UGDH | More | | Tofacitinib | hsa00051 | Fructose and mannose metabolism | 2.63E-05 | 5 | P15121, P19367, P08237, P60174, P04075 | AKR1B1, HK1, PFKM, TPI1, ALDOA | More | | Tofacitinib | hsa00052 | Galactose metabolism | 4.25E-05 | 6 | P06280, P08237, O43451, P15121, P19367, Q14376 | GLA, PFKM, MGAM, AKR1B1, HK1, GALE | More | | Tofacitinib | hsa00071 | Fatty acid degradation | 2.38E-02 | 3 | P11310, O75521, P33121 | ACADM, ECI2, ACSL1 | More | | Tofacitinib | hsa00100 | Steroid biosynthesis | 3.94E-02 | 1 | P35610 | SOAT1 | More | | Tofacitinib | hsa00190 | Oxidative phosphorylation | 3.98E-06 | 4 | Q16718, Q13488, P36542, O14521 | NDUFA5, TCIRG1, ATP5C1, SDHD | More | | Tofacitinib | hsa00220 | Arginine biosynthesis | 1.55E-06 | 3 | P15104, P05089, P49448 | GLUL, ARG1, GLUD2 | More | | Tofacitinib | hsa00230 | Purine metabolism | 3.35E-02 | 2 | Q7LG56, P51828 | RRM2B, ADCY7 | More | | Tofacitinib | hsa00250 | Alanine, aspartate and glutamate metabolism | 6.84E-05 | 3 | Q96RQ9, P49448, P15104 | IL4I1, GLUD2, GLUL | More | | Tofacitinib | hsa00270 | Cysteine and methionine metabolism | 2.39E-02 | 2 | Q96RQ9, P40926 | IL4I1, MDH2 | More | | Tofacitinib | hsa00280 | Valine, leucine and isoleucine degradation | 1.93E-04 | 6 | P55809, Q9HCC0, Q96RQ9, P05166, Q02252, P11310 | OXCT1, MCCC2, IL4I1, PCCB, ALDH6A1, ACADM | More | | Tofacitinib | hsa00310 | Lysine degradation | 2.14E-05 | 7 | Q9NVH6, Q96KQ7, Q8NEZ4, Q13029, O15047, Q02809, P51648 | TMLHE, EHMT2, MLL3, PRDM2, SETD1A, PLOD1, ALDH3A2 | More | | Tofacitinib | hsa00330 | Arginine and proline metabolism | 2.73E-02 | 1 | P17707 | AMD1 | More | | Tofacitinib | hsa00380 | Tryptophan metabolism | 3.02E-02 | 1 | Q16613 | AANAT | More | | Tofacitinib | hsa00410 | beta-Alanine metabolism | 3.98E-02 | 1 | Q6ZQY3 | GADL1 | More | | Tofacitinib | hsa00471 | D-Glutamine and D-glutamate metabolism | 1.54E-03 | 2 | Q7Z3D6, P49448 | C14orf159, GLUD2 | More | | Tofacitinib | hsa00500 | Starch and sucrose metabolism | 6.81E-07 | 4 | O43451, P46976, P35573, P06737 | MGAM, GYG1, AGL, PYGL | More | | Tofacitinib | hsa00510 | N-Glycan biosynthesis | 1.10E-03 | 4 | O94777, P15907, Q9BVK2, Q9NR34 | DPM2, ST6GAL1, ALG8, MAN1C1 | More | | Tofacitinib | hsa00513 | Various types of N-glycan biosynthesis | 4.83E-02 | 1 | Q9NR34 | MAN1C1 | More | | Tofacitinib | hsa00520 | Amino sugar and nucleotide sugar metabolism | 2.98E-05 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Tofacitinib | hsa00531 | Glycosaminoglycan degradation | 3.78E-02 | 1 | P15586 | GNS | More | | Tofacitinib | hsa00562 | Inositol phosphate metabolism | 4.54E-04 | 5 | Q9NRR6, P27987, O14732, P19174, P42338 | INPP5E, ITPKB, IMPA2, PLCG1, PIK3CB | More | | Tofacitinib | hsa00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 3.28E-03 | 2 | O94777, Q14442 | DPM2, PIGH | More | | Tofacitinib | hsa00564 | Glycerophospholipid metabolism | 1.25E-04 | 6 | P48651, Q9Y6K0, P35790, P23743, O14494, Q3LIE5 | PTDSS1, CEPT1, CHKA, DGKA, PLPP1, ADPRM | More | | Tofacitinib | hsa00590 | Arachidonic acid metabolism | 2.97E-02 | 1 | P09917 | ALOX5 | More | | Tofacitinib | hsa00600 | Sphingolipid metabolism | 2.65E-03 | 3 | Q9BX95, Q06136, P15289 | SGPP1, FVT1, ARSA | More | | Tofacitinib | hsa00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 4.27E-07 | 2 | P06865, O75752 | HEXA, B3GALNT1 | More | | Tofacitinib | hsa00604 | Glycosphingolipid biosynthesis - ganglio series | 2.46E-02 | 2 | P06865, Q9H4F1 | HEXA, ST6GALNAC4 | More | | Tofacitinib | hsa00620 | Pyruvate metabolism | 9.80E-04 | 4 | P40926, P07195, P14550, P11766 | MDH2, LDHB, AKR1A1, ADH5 | More | | Tofacitinib | hsa00630 | Glyoxylate and dicarboxylate metabolism | 3.78E-10 | 4 | P40925, P40926, P05166, P15104 | MDH1, MDH2, PCCB, GLUL | More | | Tofacitinib | hsa00640 | Propanoate metabolism | 3.83E-02 | 2 | Q02252, Q9P2R7 | ALDH6A1, SUCLA2 | More | | Tofacitinib | hsa00670 | One carbon pool by folate | 1.72E-05 | 3 | O95954, P04818, Q99707 | FTCD, TYMS, MTR | More | | Tofacitinib | hsa00730 | Thiamine metabolism | 1.55E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Tofacitinib | hsa00740 | Riboflavin metabolism | 4.77E-02 | 1 | P30043 | BLVRB | More | | Tofacitinib | hsa00750 | Vitamin B6 metabolism | 4.45E-02 | 1 | O00764 | PDXK | More | | Tofacitinib | hsa00770 | Pantothenate and CoA biosynthesis | 3.98E-02 | 1 | Q6ZQY3 | GADL1 | More | | Tofacitinib | hsa00785 | Lipoic acid metabolism | 4.32E-02 | 1 | Q9Y234 | LIPT1 | More | | Tofacitinib | hsa00790 | Folate biosynthesis | 1.04E-02 | 3 | Q92820, P05186, P42330 | GGH, ALPL, AKR1C3 | More | | Tofacitinib | hsa00830 | Retinol metabolism | 3.35E-04 | 5 | P00325, P11766, P00352, Q9BPW9, O75911 | ADH1B, ADH5, ALDH1A1, DHRS9, DHRS3 | More | | Tofacitinib | hsa00860 | Porphyrin and chlorophyll metabolism | 2.26E-03 | 3 | P36551, P53004, P30043 | CPOX, BLVRA, BLVRB | More | | Tofacitinib | hsa00900 | Terpenoid backbone biosynthesis | 4.22E-02 | 2 | P49354, Q9UHG3 | FNTA, PCYOX1 | More | | Tofacitinib | hsa00910 | Nitrogen metabolism | 4.40E-03 | 2 | P15104, P49448 | GLUL, GLUD2 | More | | Tofacitinib | hsa00970 | Aminoacyl-tRNA biosynthesis | 1.56E-03 | 2 | P54136, P14868 | RARS1, DARS | More | | Tofacitinib | hsa00983 | Drug metabolism - other enzymes | 1.07E-06 | 5 | P04183, P20839, P32320, P05164, Q16772 | TK1, IMPDH1, CDA, MPO, GSTA3 | More | | Tofacitinib | hsa01040 | Biosynthesis of unsaturated fatty acids | 4.28E-02 | 1 | P22307 | SCP2 | More | | Tofacitinib | hsa01100 | Metabolic pathways | 8.01E-07 | 69 | Q9NR34, Q9Y234, P35790, P05089, P21953, Q16772, Q9UJ14, P30041, P15104, P19367, P42338, Q9Y217, P48426, P27987, Q96DU7, P22557, Q6ZQY3, P32320, Q08828, Q02153, P20839, P22748, P40926, P55809, P06280, O94777, Q16875, O43286, O43451, P53004, Q9Y6K0, P05186, P24666, P15121, P08237, Q86XP1, O95861, Q96RQ9, Q9HCC0, P33121, Q9UHK6, Q86VZ5, Q96G23, P09917, P48651, Q9BVK2, P57054, Q14442, Q9UNP4, Q9H4F1, Q9BX95, Q9BRR6, P32321, P49448, Q9BPW9, O75911, Q9UHY7, P43490, P46976, P06737, Q969G6, P05166, P14927, P12074, P05496, Q99437, O15239, O15047, Q9NVH6 | MAN1C1, LIPT1, CHKA, ARG1, BCKDHB, GSTA3, GGTL3, PRDX6, GLUL, HK1, PIK3CB, MTMR6, PIP4K2A, ITPKB, ITPKC, ALAS2, GADL1, CDA, ADCY1, GUCY1B3, IMPDH1, CA4, MDH2, OXCT1, GLA, DPM2, PFKFB3, B4GALT5, MGAM, BLVRA, CEPT1, ALPL, ACP1, AKR1B1, PFKM, DGKH, BPNT1, IL4I1, MCCC2, ACSL1, AMACR, SGMS1, LASS2, ALOX5, PTDSS1, ALG8, PIGP, PIGH, ST3GAL5, ST6GALNAC4, SGPP1, ADPGK, DCTD, GLUD2, DHRS9, DHRS3, ENOPH1, PBEF1, GYG1, PYGL, RFK, PCCB, UQCRB, COX6A1, ATP5G1, ATP6V0B, NDUFA1, SETD1A, TMLHE | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9NR34 | MAN1C1 | Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC | -0.716 | Q9UEW8 | STK39 | STE20/SPS1-related proline-alanine-rich protein kinase | Q9Y234 | LIPT1 | Lipoyltransferase 1, mitochondrial | -0.733 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | Q9Y234 | LIPT1 | Lipoyltransferase 1, mitochondrial | 0.829 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P35790 | CHKA | Choline kinase alpha | -0.778 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05089 | ARG1 | Arginase-1 | 0.702 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P21953 | BCKDHB | 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial | 0.765 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | Q16772 | GSTA3 | Glutathione S-transferase A3 | -0.791 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q9UJ14 | GGTL3 | Glutathione hydrolase 7 | -0.717 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P30041 | PRDX6 | Peroxiredoxin-6 | 0.893 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P15104 | GLUL | Glutamine synthetase | -0.819 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P15104 | GLUL | Glutamine synthetase | -0.718 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P19367 | HK1 | Hexokinase-1 | 0.777 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.733 | Q9UEW8 | STK39 | STE20/SPS1-related proline-alanine-rich protein kinase | Q9Y217 | MTMR6 | Myotubularin-related protein 6 | 0.766 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P48426 | PIP4K2A | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | 0.745 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P27987 | ITPKB | Inositol-trisphosphate 3-kinase B | 0.745 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q96DU7 | ITPKC | Inositol-trisphosphate 3-kinase C | 0.879 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P22557 | ALAS2 | 5-aminolevulinate synthase, erythroid-specific, mitochondrial | 0.707 | Q9UEW8 | STK39 | STE20/SPS1-related proline-alanine-rich protein kinase | Q6ZQY3 | GADL1 | Acidic amino acid decarboxylase GADL1 | -0.701 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32320 | CDA | Cytidine deaminase | 0.701 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q08828 | ADCY1 | Adenylate cyclase type 1 | -0.748 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q02153 | GUCY1B3 | Guanylate cyclase soluble subunit beta-1 | 0.847 | Q9UEW8 | STK39 | STE20/SPS1-related proline-alanine-rich protein kinase | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | -0.789 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | 0.828 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P22748 | CA4 | Carbonic anhydrase 4 | 0.767 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | -0.731 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P55809 | OXCT1 | Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial | -0.746 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06280 | GLA | Alpha-galactosidase A | 0.714 | Q9UEW8 | STK39 | STE20/SPS1-related proline-alanine-rich protein kinase | O94777 | DPM2 | Dolichol phosphate-mannose biosynthesis regulatory protein | -0.722 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 0.849 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43286 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | 0.917 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43451 | MGAM | Maltase-glucoamylase | 0.871 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P53004 | BLVRA | Biliverdin reductase A | 0.901 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | Q9Y6K0 | CEPT1 | Choline/ethanolaminephosphotransferase 1 | 0.802 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | 0.901 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24666 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | -0.832 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | 0.732 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P08237 | PFKM | ATP-dependent 6-phosphofructokinase, muscle type | 0.82 | Q9UEW8 | STK39 | STE20/SPS1-related proline-alanine-rich protein kinase | Q86XP1 | DGKH | Diacylglycerol kinase eta | 0.762 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q86XP1 | DGKH | Diacylglycerol kinase eta | 0.804 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | O95861 | BPNT1 | 3'(2'),5'-bisphosphate nucleotidase 1 | -0.702 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q96RQ9 | IL4I1 | L-amino-acid oxidase | 0.761 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9HCC0 | MCCC2 | Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial | -0.782 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | 0.886 | Q9UEW8 | STK39 | STE20/SPS1-related proline-alanine-rich protein kinase | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | 0.745 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | 0.839 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | Q86VZ5 | SGMS1 | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | -0.795 | Q9UEW8 | STK39 | STE20/SPS1-related proline-alanine-rich protein kinase | Q96G23 | LASS2 | Ceramide synthase 2 | 0.756 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | -0.705 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P48651 | PTDSS1 | Phosphatidylserine synthase 1 | 0.802 | Q9UEW8 | STK39 | STE20/SPS1-related proline-alanine-rich protein kinase | Q9BVK2 | ALG8 | Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase | 0.876 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P57054 | PIGP | Phosphatidylinositol N-acetylglucosaminyltransferase subunit P | -0.881 | Q9UEW8 | STK39 | STE20/SPS1-related proline-alanine-rich protein kinase | Q14442 | PIGH | Phosphatidylinositol N-acetylglucosaminyltransferase subunit H | 0.806 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | 0.743 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | -0.819 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q9H4F1 | ST6GALNAC4 | Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase | -0.785 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.743 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q9BRR6 | ADPGK | ADP-dependent glucokinase | -0.71 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P32321 | DCTD | Deoxycytidylate deaminase | 0.79 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32321 | DCTD | Deoxycytidylate deaminase | -0.748 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P49448 | GLUD2 | Glutamate dehydrogenase 2, mitochondrial | 0.74 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | -0.798 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O75911 | DHRS3 | Short-chain dehydrogenase/reductase 3 | -0.81 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UHY7 | ENOPH1 | Enolase-phosphatase E1 | -0.737 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.883 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P46976 | GYG1 | Glycogenin-1 | -0.82 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P46976 | GYG1 | Glycogenin-1 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06737 | PYGL | Glycogen phosphorylase, liver form | 0.863 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | Q969G6 | RFK | Riboflavin kinase | 0.797 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P05166 | PCCB | Propionyl-CoA carboxylase beta chain, mitochondrial | -0.714 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P14927 | UQCRB | Cytochrome b-c1 complex subunit 7 | 0.721 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | -0.715 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P05496 | ATP5G1 | ATP synthase F(0) complex subunit C1, mitochondrial | -0.815 | Q9UEW8 | STK39 | STE20/SPS1-related proline-alanine-rich protein kinase | Q99437 | ATP6V0B | V-type proton ATPase 21 kDa proteolipid subunit c'' | -0.713 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | -0.834 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | O15047 | SETD1A | Histone-lysine N-methyltransferase SETD1A | -0.831 | Q9UEW8 | STK39 | STE20/SPS1-related proline-alanine-rich protein kinase | Q9NVH6 | TMLHE | Trimethyllysine dioxygenase, mitochondrial | 0.715 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q9NVH6 | TMLHE | Trimethyllysine dioxygenase, mitochondrial | 0.74 |
| Tofacitinib | hsa01200 | Carbon metabolism | 2.13E-02 | 2 | P52209, P37837 | PGD, TALDO1 | More | | Tofacitinib | hsa01212 | Fatty acid metabolism | 4.62E-02 | 2 | P33121, P11310 | ACSL1, ACADM | More | | Tofacitinib | hsa01230 | Biosynthesis of amino acids | 1.89E-04 | 6 | P51854, P60891, Q99707, P50213, P05089, P37837 | TKTL1, PRPS1, MTR, IDH3A, ARG1, TALDO1 | More | | Tofacitinib | hsa01240 | Biosynthesis of cofactors | 2.85E-04 | 7 | Q969G6, P13716, P36551, P22557, O60701, P14618, Q9Y234 | RFK, ALAD, CPOX, ALAS2, UGDH, PKM2, LIPT1 | More | | Tofacitinib | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 3.18E-04 | 2 | P04049, P08069 | RAF1, IGF1R | More | | Tofacitinib | hsa01522 | Endocrine resistance | 2.90E-05 | 8 | P22694, P04049, Q9UM47, P04637, P42773, P08069, P10415, Q13323 | PRKACB, RAF1, NOTCH3, TP53, CDKN2C, IGF1R, BCL2, BIK | More | | Tofacitinib | hsa01523 | Antifolate resistance | 2.08E-04 | 4 | P41440, Q92820, P04818, P01375 | SLC19A1, GGH, TYMS, TNF | More | | Tofacitinib | hsa01524 | Platinum drug resistance | 2.37E-05 | 8 | Q13489, Q14790, P48023, P78417, P40692, P23025, P52701, P31751 | BIRC3, CASP8, FASLG, GSTO1, MLH1, XPA, MSH6, AKT2 | More | | Tofacitinib | hsa02010 | ABC transporters | 4.48E-02 | 1 | Q8IZY2 | ABCA7 | More | | Tofacitinib | hsa03010 | Ribosome | 7.89E-13 | 21 | P26373, P62753, P42677, P25398, P32969, P62917, P62829, P46776, Q9H0U6, Q07020, P62888, P62899, P62910, P18077, P61927, P61513, Q02878, P36578, P27635, P05386, P23396 | RPL13, RPS6, RPS27, RPS12, RPL9, RPL8, RPL23, RPL27A, MRPL18, RPL18, RPL30, RPL31, RPL32, RPL35A, RPL37, RPL37A, RPL6, RPL4, RPL10, RPLP1, RPS3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q9NQU5 | PAK6 | Serine/threonine-protein kinase PAK 6 | P26373 | RPL13 | 60S ribosomal protein L13 | 0.752 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | P62753 | RPS6 | 40S ribosomal protein S6 | 0.736 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P62753 | RPS6 | 40S ribosomal protein S6 | 0.716 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P62753 | RPS6 | 40S ribosomal protein S6 | 0.716 | Q9NQU5 | PAK6 | Serine/threonine-protein kinase PAK 6 | P42677 | RPS27 | 40S ribosomal protein S27 | 0.731 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P42677 | RPS27 | 40S ribosomal protein S27 | 0.819 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P25398 | RPS12 | 40S ribosomal protein S12 | 0.784 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P32969 | RPL9 | 60S ribosomal protein L9 | 0.78 | Q9NQU5 | PAK6 | Serine/threonine-protein kinase PAK 6 | P62917 | RPL8 | 60S ribosomal protein L8 | 0.824 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P62917 | RPL8 | 60S ribosomal protein L8 | 0.813 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | P62829 | RPL23 | 60S ribosomal protein L23 | 0.726 | Q9NQU5 | PAK6 | Serine/threonine-protein kinase PAK 6 | P46776 | RPL27A | 60S ribosomal protein L27a | 0.719 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P46776 | RPL27A | 60S ribosomal protein L27a | 0.716 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P46776 | RPL27A | 60S ribosomal protein L27a | 0.79 | Q9NQU5 | PAK6 | Serine/threonine-protein kinase PAK 6 | Q9H0U6 | MRPL18 | 39S ribosomal protein L18, mitochondrial | 0.706 | Q9NQU5 | PAK6 | Serine/threonine-protein kinase PAK 6 | Q07020 | RPL18 | 60S ribosomal protein L18 | 0.74 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | Q07020 | RPL18 | 60S ribosomal protein L18 | 0.778 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | P62888 | RPL30 | 60S ribosomal protein L30 | 0.725 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P62899 | RPL31 | 60S ribosomal protein L31 | 0.753 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P62910 | RPL32 | 60S ribosomal protein L32 | 0.704 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P18077 | RPL35A | 60S ribosomal protein L35a | 0.833 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | P61927 | RPL37 | 60S ribosomal protein L37 | 0.761 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P61927 | RPL37 | 60S ribosomal protein L37 | 0.709 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | P61513 | RPL37A | 60S ribosomal protein L37a | 0.728 | Q9NQU5 | PAK6 | Serine/threonine-protein kinase PAK 6 | Q02878 | RPL6 | 60S ribosomal protein L6 | 0.762 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | Q02878 | RPL6 | 60S ribosomal protein L6 | 0.795 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | P36578 | RPL4 | 60S ribosomal protein L4 | 0.725 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P36578 | RPL4 | 60S ribosomal protein L4 | 0.74 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P36578 | RPL4 | 60S ribosomal protein L4 | 0.873 | Q9NQU5 | PAK6 | Serine/threonine-protein kinase PAK 6 | P27635 | RPL10 | 60S ribosomal protein L10 | 0.715 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P27635 | RPL10 | 60S ribosomal protein L10 | 0.73 | Q9NQU5 | PAK6 | Serine/threonine-protein kinase PAK 6 | P05386 | RPLP1 | 60S acidic ribosomal protein P1 | 0.77 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P05386 | RPLP1 | 60S acidic ribosomal protein P1 | 0.837 | Q9NQU5 | PAK6 | Serine/threonine-protein kinase PAK 6 | P23396 | RPS3 | 40S ribosomal protein S3 | 0.803 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P23396 | RPS3 | 40S ribosomal protein S3 | 0.899 |
| Tofacitinib | hsa03013 | RNA transport | 9.38E-21 | 29 | P62826, O14980, P52298, Q09161, O14893, P61326, Q15287, Q9UBU9, Q9H307, Q7Z3B4, P35658, P63279, P68104, P47813, O14602, Q14152, P55884, O15371, O75822, P78345, Q9H777, P11940, P20042, Q14240, Q9BZI7, Q9Y6A5, Q14232, Q06787, P51114 | RAN, XPO1, NCBP2, NCBP1, GEMIN2, MAGOH, RNPS1, NXF1, PNN, NUP54, NUP214, UBE2I, EEF1A1, EIF1AX, EIF1AY, EIF3A, EIF3B, EIF3D, EIF3J, RPP38, ELAC1, PABPC1, EIF2S2, EIF4A2, UPF3B, TACC3, EIF2B1, FMR1, FXR1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O14976 | GAK | Cyclin-G-associated kinase | P62826 | RAN | GTP-binding nuclear protein Ran | 0.774 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | P62826 | RAN | GTP-binding nuclear protein Ran | 0.751 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | P62826 | RAN | GTP-binding nuclear protein Ran | 0.92 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P62826 | RAN | GTP-binding nuclear protein Ran | 0.732 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P62826 | RAN | GTP-binding nuclear protein Ran | 0.767 | Q9P289 | STK26 | Serine/threonine-protein kinase 26 | O14980 | XPO1 | Exportin-1 | 0.781 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | O14980 | XPO1 | Exportin-1 | 0.799 | Q13523 | PRPF4B | Serine/threonine-protein kinase PRP4 homolog | O14980 | XPO1 | Exportin-1 | 0.922 | Q07912 | TNK2 | Activated CDC42 kinase 1 | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | -0.701 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q09161 | NCBP1 | Nuclear cap-binding protein subunit 1 | 0.771 | Q13523 | PRPF4B | Serine/threonine-protein kinase PRP4 homolog | Q09161 | NCBP1 | Nuclear cap-binding protein subunit 1 | 0.781 | Q9Y6R4 | MAP3K4 | Mitogen-activated protein kinase kinase kinase 4 | Q09161 | NCBP1 | Nuclear cap-binding protein subunit 1 | 0.772 | Q07912 | TNK2 | Activated CDC42 kinase 1 | O14893 | GEMIN2 | Gem-associated protein 2 | -0.752 | Q9P289 | STK26 | Serine/threonine-protein kinase 26 | O14893 | GEMIN2 | Gem-associated protein 2 | 0.765 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | O14893 | GEMIN2 | Gem-associated protein 2 | 0.72 | Q13523 | PRPF4B | Serine/threonine-protein kinase PRP4 homolog | O14893 | GEMIN2 | Gem-associated protein 2 | 0.73 | P49759 | CLK1 | Dual specificity protein kinase CLK1 | O14893 | GEMIN2 | Gem-associated protein 2 | 0.76 | Q13523 | PRPF4B | Serine/threonine-protein kinase PRP4 homolog | P61326 | MAGOH | Protein mago nashi homolog | 0.803 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | Q15287 | RNPS1 | RNA-binding protein with serine-rich domain 1 | 0.729 | O14976 | GAK | Cyclin-G-associated kinase | Q15287 | RNPS1 | RNA-binding protein with serine-rich domain 1 | 0.763 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | Q15287 | RNPS1 | RNA-binding protein with serine-rich domain 1 | 0.868 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | Q15287 | RNPS1 | RNA-binding protein with serine-rich domain 1 | 0.748 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | Q15287 | RNPS1 | RNA-binding protein with serine-rich domain 1 | 0.719 | O14976 | GAK | Cyclin-G-associated kinase | Q9UBU9 | NXF1 | Nuclear RNA export factor 1 | 0.827 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | Q9UBU9 | NXF1 | Nuclear RNA export factor 1 | 0.786 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q9UBU9 | NXF1 | Nuclear RNA export factor 1 | 0.79 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | Q9UBU9 | NXF1 | Nuclear RNA export factor 1 | 0.701 | Q9P289 | STK26 | Serine/threonine-protein kinase 26 | Q9H307 | PNN | Pinin | 0.716 | Q13523 | PRPF4B | Serine/threonine-protein kinase PRP4 homolog | Q9H307 | PNN | Pinin | 0.714 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q7Z3B4 | NUP54 | Nucleoporin p54 | 0.883 | Q13523 | PRPF4B | Serine/threonine-protein kinase PRP4 homolog | Q7Z3B4 | NUP54 | Nucleoporin p54 | 0.743 | Q9Y6R4 | MAP3K4 | Mitogen-activated protein kinase kinase kinase 4 | Q7Z3B4 | NUP54 | Nucleoporin p54 | 0.752 | Q9P289 | STK26 | Serine/threonine-protein kinase 26 | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.713 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.708 | Q13523 | PRPF4B | Serine/threonine-protein kinase PRP4 homolog | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.804 | Q9Y6R4 | MAP3K4 | Mitogen-activated protein kinase kinase kinase 4 | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.937 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.769 | O14976 | GAK | Cyclin-G-associated kinase | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.766 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.737 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.805 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.739 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.743 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P68104 | EEF1A1 | Elongation factor 1-alpha 1 | 0.848 | O14976 | GAK | Cyclin-G-associated kinase | P68104 | EEF1A1 | Elongation factor 1-alpha 1 | 0.705 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P68104 | EEF1A1 | Elongation factor 1-alpha 1 | 0.721 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P68104 | EEF1A1 | Elongation factor 1-alpha 1 | 0.797 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | P47813 | EIF1AX | Eukaryotic translation initiation factor 1A, X-chromosomal | 0.844 | Q13523 | PRPF4B | Serine/threonine-protein kinase PRP4 homolog | P47813 | EIF1AX | Eukaryotic translation initiation factor 1A, X-chromosomal | 0.773 | Q07912 | TNK2 | Activated CDC42 kinase 1 | O14602 | EIF1AY | Eukaryotic translation initiation factor 1A, Y-chromosomal | -0.826 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | 0.869 | Q13523 | PRPF4B | Serine/threonine-protein kinase PRP4 homolog | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | 0.9 | Q9Y6R4 | MAP3K4 | Mitogen-activated protein kinase kinase kinase 4 | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | 0.776 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P55884 | EIF3B | Eukaryotic translation initiation factor 3 subunit B | -0.823 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | O15371 | EIF3D | Eukaryotic translation initiation factor 3 subunit D | 0.782 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | 0.77 | Q13523 | PRPF4B | Serine/threonine-protein kinase PRP4 homolog | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | 0.848 | Q9Y6R4 | MAP3K4 | Mitogen-activated protein kinase kinase kinase 4 | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | 0.836 | Q07912 | TNK2 | Activated CDC42 kinase 1 | P78345 | RPP38 | Ribonuclease P protein subunit p38 | -0.717 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | Q9H777 | ELAC1 | Zinc phosphodiesterase ELAC protein 1 | 0.785 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P11940 | PABPC1 | Polyadenylate-binding protein 1 | 0.767 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | P11940 | PABPC1 | Polyadenylate-binding protein 1 | 0.721 | O14976 | GAK | Cyclin-G-associated kinase | P20042 | EIF2S2 | Eukaryotic translation initiation factor 2 subunit 2 | 0.711 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | P20042 | EIF2S2 | Eukaryotic translation initiation factor 2 subunit 2 | 0.753 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | P20042 | EIF2S2 | Eukaryotic translation initiation factor 2 subunit 2 | 0.72 | Q9P289 | STK26 | Serine/threonine-protein kinase 26 | Q14240 | EIF4A2 | Eukaryotic initiation factor 4A-II | 0.703 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q14240 | EIF4A2 | Eukaryotic initiation factor 4A-II | 0.849 | Q13523 | PRPF4B | Serine/threonine-protein kinase PRP4 homolog | Q14240 | EIF4A2 | Eukaryotic initiation factor 4A-II | 0.844 | P49759 | CLK1 | Dual specificity protein kinase CLK1 | Q14240 | EIF4A2 | Eukaryotic initiation factor 4A-II | 0.704 | Q9P289 | STK26 | Serine/threonine-protein kinase 26 | Q9BZI7 | UPF3B | Regulator of nonsense transcripts 3B | 0.732 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q9BZI7 | UPF3B | Regulator of nonsense transcripts 3B | 0.764 | P49759 | CLK1 | Dual specificity protein kinase CLK1 | Q9BZI7 | UPF3B | Regulator of nonsense transcripts 3B | 0.758 | Q13523 | PRPF4B | Serine/threonine-protein kinase PRP4 homolog | Q9Y6A5 | TACC3 | Transforming acidic coiled-coil-containing protein 3 | -0.772 | Q9Y6R4 | MAP3K4 | Mitogen-activated protein kinase kinase kinase 4 | Q9Y6A5 | TACC3 | Transforming acidic coiled-coil-containing protein 3 | -0.701 | O14976 | GAK | Cyclin-G-associated kinase | Q14232 | EIF2B1 | Translation initiation factor eIF-2B subunit alpha | 0.767 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | Q14232 | EIF2B1 | Translation initiation factor eIF-2B subunit alpha | 0.774 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | Q14232 | EIF2B1 | Translation initiation factor eIF-2B subunit alpha | 0.727 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q14232 | EIF2B1 | Translation initiation factor eIF-2B subunit alpha | 0.749 | Q9P289 | STK26 | Serine/threonine-protein kinase 26 | Q06787 | FMR1 | Synaptic functional regulator FMR1 | 0.796 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q06787 | FMR1 | Synaptic functional regulator FMR1 | 0.863 | Q13523 | PRPF4B | Serine/threonine-protein kinase PRP4 homolog | Q06787 | FMR1 | Synaptic functional regulator FMR1 | 0.753 | P49759 | CLK1 | Dual specificity protein kinase CLK1 | Q06787 | FMR1 | Synaptic functional regulator FMR1 | 0.793 | Q9P289 | STK26 | Serine/threonine-protein kinase 26 | P51114 | FXR1 | Fragile X mental retardation syndrome-related protein 1 | 0.803 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | P51114 | FXR1 | Fragile X mental retardation syndrome-related protein 1 | 0.798 | Q13523 | PRPF4B | Serine/threonine-protein kinase PRP4 homolog | P51114 | FXR1 | Fragile X mental retardation syndrome-related protein 1 | 0.724 | Q9Y6R4 | MAP3K4 | Mitogen-activated protein kinase kinase kinase 4 | P51114 | FXR1 | Fragile X mental retardation syndrome-related protein 1 | 0.81 |
| Tofacitinib | hsa03015 | mRNA surveillance pathway | 4.81E-02 | 2 | Q9BZI7, O94913 | UPF3B, PCF11 | More | | Tofacitinib | hsa03020 | RNA polymerase | 5.44E-09 | 4 | P30876, P24928, P62487, Q9Y535 | POLR2B, POLR2A, POLR2G, POLR3H | More | | Tofacitinib | hsa03022 | Basal transcription factors | 3.50E-02 | 3 | P20226, O00268, Q15544 | TBP, TAF4, TAF11 | More | | Tofacitinib | hsa03040 | Spliceosome | 1.92E-08 | 15 | Q14562, O43143, O60508, P08579, P26368, O75940, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX8, DHX15, CDC40, SNRPB2, U2AF2, SMNDC1, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | -0.708 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.781 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | -0.725 | P29375 | JARID1A | Lysine-specific demethylase 5A | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.794 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.8 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.837 | P07948 | LYN | Tyrosine-protein kinase Lyn | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.814 | P29375 | JARID1A | Lysine-specific demethylase 5A | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.875 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.702 | P07948 | LYN | Tyrosine-protein kinase Lyn | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.739 | P07948 | LYN | Tyrosine-protein kinase Lyn | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.775 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | O75940 | SMNDC1 | Survival of motor neuron-related-splicing factor 30 | 0.723 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.742 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.725 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.895 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.835 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.716 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.862 | P07948 | LYN | Tyrosine-protein kinase Lyn | P84103 | SFRS3 | Serine/arginine-rich splicing factor 3 | -0.79 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.781 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.732 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.738 | P07948 | LYN | Tyrosine-protein kinase Lyn | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.732 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.926 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q9Y2W2 | WBP11 | WW domain-binding protein 11 | -0.734 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.761 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.768 | P07948 | LYN | Tyrosine-protein kinase Lyn | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | -0.742 |
| Tofacitinib | hsa03050 | Proteasome | 4.83E-02 | 1 | P55036 | PSMD4 | More | | Tofacitinib | hsa03060 | Protein export | 3.67E-09 | 4 | Q15070, P37108, O76094, Q15005 | OXA1L, SRP14, SRP72, SPCS2 | More | | Tofacitinib | hsa03320 | PPAR signaling pathway | 4.33E-02 | 2 | Q6PCB7, Q9UNU6 | SLC27A1, CYP8B1 | More | | Tofacitinib | hsa03430 | Mismatch repair | 4.38E-02 | 1 | P20585 | MSH3 | More | | Tofacitinib | hsa03450 | Non-homologous end-joining | 3.17E-03 | 2 | Q9NP87, P13010 | POLM, XRCC5 | More | | Tofacitinib | hsa03460 | Fanconi anemia pathway | 8.90E-04 | 3 | P40692, O60673, Q9UNA4 | MLH1, REV3L, POLI | More | | Tofacitinib | hsa04010 | MAPK signaling pathway | 8.69E-05 | 4 | P04049, P08069, Q9H2K8, Q12933 | RAF1, IGF1R, TAOK3, TRAF2 | More | | Tofacitinib | hsa04012 | ErbB signaling pathway | 3.61E-05 | 7 | Q13153, P16333, Q13191, P19174, P42338, P01106, P04049 | PAK1, NCK1, CBLB, PLCG1, PIK3CB, MYC, RAF1 | More | | Tofacitinib | hsa04014 | Ras signaling pathway | 2.30E-05 | 4 | P04049, P31751, P08069, P0DP23 | RAF1, AKT2, IGF1R, CALM1 | More | | Tofacitinib | hsa04015 | Rap1 signaling pathway | 3.20E-07 | 6 | P04049, P08069, P06213, O00522, P31751, P0DP23 | RAF1, IGF1R, INSR, KRIT1, AKT2, CALM1 | More | | Tofacitinib | hsa04020 | Calcium signaling pathway | 2.78E-06 | 12 | Q96DU7, Q08828, P21796, P45880, Q13557, P21860, P30679, P0DP24, P0DP23, P05141, P51828, P23634 | ITPKC, ADCY1, VDAC1, VDAC2, CAMK2D, ERBB3, GNA15, CALM2, CALM1, SLC25A5, ADCY7, ATP2B4 | More | | Tofacitinib | hsa04022 | cGMP-PKG signaling pathway | 1.32E-07 | 12 | Q02153, P04049, Q99941, P18848, P23634, P31751, Q08828, P51828, P05141, P45880, P0DP24, P0DP23 | GUCY1B3, RAF1, CREBL1, ATF4, ATP2B4, AKT2, ADCY1, ADCY7, SLC25A5, VDAC2, CALM2, CALM1 | More | | Tofacitinib | hsa04024 | cAMP signaling pathway | 2.01E-05 | 9 | Q08828, P51828, P42338, P31751, P0DP23, P04049, Q13370, Q13009, Q13153 | ADCY1, ADCY7, PIK3CB, AKT2, CALM1, RAF1, PDE3B, TIAM1, PAK1 | More | | Tofacitinib | hsa04060 | Cytokine-cytokine receptor interaction | 6.46E-05 | 17 | P14784, P27930, P14778, P37173, P26842, Q06643, Q13651, Q9HBE5, P78552, P25024, Q9UBD3, P47992, P09341, P19875, P80075, P01730, Q93038 | IL2RB, IL1R2, IL1R1, TGFBR2, CD27, LTB, IL10RA, IL21R, IL13RA1, CXCR1, XCL2, XCL1, CXCL1, CXCL2, CCL8, CD4, TNFRSF25 | More | | Tofacitinib | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 1.29E-04 | 9 | Q8NHW4, P09341, P25024, P25025, P47992, Q9UBD3, Q13651, P14784, P01375 | CCL4L2, CXCL1, CXCR1, CXCR2, XCL1, XCL2, IL10RA, IL2RB, TNF | More | | Tofacitinib | hsa04062 | Chemokine signaling pathway | 4.07E-05 | 18 | P25024, P09341, P47992, Q9UBD3, P07948, P42338, P19174, P62873, P63218, P50151, P43250, P49407, Q08881, Q13009, P14598, P42224, P04049, P25963 | CXCR1, CXCL1, XCL1, XCL2, LYN, PIK3CB, PLCG1, GNB1, GNG5, GNG10, GRK6, ARRB1, ITK, TIAM1, NCF1, STAT1, RAF1, NFKBIA | More | | Tofacitinib | hsa04064 | NF-kappa B signaling pathway | 1.03E-15 | 25 | P10415, Q13489, P51617, O00463, Q13546, P14778, P01584, P01375, P29965, P19174, Q04759, Q9UDY8, Q13077, Q16548, P07948, P06239, Q8WV28, Q13315, P63279, P24522, Q8NHW4, P09341, P19875, Q06643, Q9NQC7 | BCL2, BIRC3, IRAK1, TRAF5, RIPK1, IL1R1, IL1B, TNF, CD40LG, PLCG1, PRKCQ, MALT1, TRAF1, BCL2A1, LYN, LCK, BLNK, ATM, UBE2I, GADD45A, CCL4L2, CXCL1, CXCL2, LTB, CYLD | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42681 | TXK | Tyrosine-protein kinase TXK | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.716 | Q07912 | TNK2 | Activated CDC42 kinase 1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.7 | P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.744 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.807 | P17252 | PRKCA | Protein kinase C alpha type | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.849 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | 1 | P42681 | TXK | Tyrosine-protein kinase TXK | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.827 | Q04759 | PRKCQ | Protein kinase C theta type | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.81 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.837 | P06239 | LCK | Tyrosine-protein kinase Lck | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.718 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.945 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.735 | Q07912 | TNK2 | Activated CDC42 kinase 1 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | 0.702 | P24723 | PRKCH | Protein kinase C eta type | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.705 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | P06239 | LCK | Tyrosine-protein kinase Lck | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.782 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.854 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P01584 | IL1B | Interleukin-1 beta | 0.799 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P01584 | IL1B | Interleukin-1 beta | 0.735 | Q04759 | PRKCQ | Protein kinase C theta type | P01375 | TNF | Tumor necrosis factor | -0.725 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | P17252 | PRKCA | Protein kinase C alpha type | P29965 | CD40LG | CD40 ligand | 0.788 | P24723 | PRKCH | Protein kinase C eta type | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.767 | P42681 | TXK | Tyrosine-protein kinase TXK | Q04759 | PRKCQ | Protein kinase C theta type | 0.876 | Q04759 | PRKCQ | Protein kinase C theta type | Q04759 | PRKCQ | Protein kinase C theta type | 1 | P24723 | PRKCH | Protein kinase C eta type | Q04759 | PRKCQ | Protein kinase C theta type | 0.791 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q04759 | PRKCQ | Protein kinase C theta type | 0.803 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q04759 | PRKCQ | Protein kinase C theta type | -0.737 | Q07912 | TNK2 | Activated CDC42 kinase 1 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.801 | P17252 | PRKCA | Protein kinase C alpha type | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.769 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.721 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.741 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.73 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.83 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.801 | P42681 | TXK | Tyrosine-protein kinase TXK | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.756 | Q04759 | PRKCQ | Protein kinase C theta type | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.76 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.875 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.877 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.742 | P06239 | LCK | Tyrosine-protein kinase Lck | P07948 | LYN | Tyrosine-protein kinase Lyn | -0.701 | P42681 | TXK | Tyrosine-protein kinase TXK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.734 | Q04759 | PRKCQ | Protein kinase C theta type | P06239 | LCK | Tyrosine-protein kinase Lck | 0.779 | P24723 | PRKCH | Protein kinase C eta type | P06239 | LCK | Tyrosine-protein kinase Lck | 0.912 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P06239 | LCK | Tyrosine-protein kinase Lck | -0.791 | P17252 | PRKCA | Protein kinase C alpha type | Q8WV28 | BLNK | B-cell linker protein | 0.838 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q8WV28 | BLNK | B-cell linker protein | -0.816 | Q07912 | TNK2 | Activated CDC42 kinase 1 | Q13315 | ATM | Serine-protein kinase ATM | -0.755 | P17252 | PRKCA | Protein kinase C alpha type | Q13315 | ATM | Serine-protein kinase ATM | 0.739 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13315 | ATM | Serine-protein kinase ATM | 0.752 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.756 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.739 | P42681 | TXK | Tyrosine-protein kinase TXK | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.79 | Q04759 | PRKCQ | Protein kinase C theta type | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.846 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.796 | P06239 | LCK | Tyrosine-protein kinase Lck | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.724 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.75 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.758 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.756 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.756 | P42681 | TXK | Tyrosine-protein kinase TXK | P09341 | CXCL1 | Growth-regulated alpha protein | -0.881 | Q04759 | PRKCQ | Protein kinase C theta type | P09341 | CXCL1 | Growth-regulated alpha protein | -0.885 | P24723 | PRKCH | Protein kinase C eta type | P09341 | CXCL1 | Growth-regulated alpha protein | -0.707 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.7 | P06239 | LCK | Tyrosine-protein kinase Lck | P09341 | CXCL1 | Growth-regulated alpha protein | -0.805 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09341 | CXCL1 | Growth-regulated alpha protein | -0.802 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P09341 | CXCL1 | Growth-regulated alpha protein | 0.78 | P24723 | PRKCH | Protein kinase C eta type | P19875 | CXCL2 | C-X-C motif chemokine 2 | -0.853 | P24723 | PRKCH | Protein kinase C eta type | Q06643 | LTB | Lymphotoxin-beta | 0.763 | P06239 | LCK | Tyrosine-protein kinase Lck | Q06643 | LTB | Lymphotoxin-beta | 0.846 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.825 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.753 |
| Tofacitinib | hsa04066 | HIF-1 signaling pathway | 2.16E-02 | 1 | P08069 | IGF1R | More | | Tofacitinib | hsa04068 | FoxO signaling pathway | 4.41E-05 | 4 | P04049, P08069, P48023, Q96BR1 | RAF1, IGF1R, FASLG, SGK3 | More | | Tofacitinib | hsa04070 | Phosphatidylinositol signaling system | 1.11E-06 | 13 | P19174, P0DP23, Q14643, P42338, O14986, P23743, P49619, Q86XP1, Q16760, P48426, P27987, Q96DU7, P17252 | PLCG1, CALM1, ITPR1, PIK3CB, PIP5K1B, DGKA, DGKG, DGKH, DGKD, PIP4K2A, ITPKB, ITPKC, PRKCA | More | | Tofacitinib | hsa04071 | Sphingolipid signaling pathway | 1.53E-05 | 11 | P04049, P17252, P21453, Q9H228, P01375, Q96G23, Q13362, Q9BX95, P10415, Q12933, Q02156 | RAF1, PRKCA, S1PR1, EDG8, TNF, LASS2, PPP2R5C, SGPP1, BCL2, TRAF2, PRKCE | More | | Tofacitinib | hsa04072 | Phospholipase D signaling pathway | 4.96E-05 | 8 | P04049, P31751, Q9UQC2, O14986, Q15438, Q08828, P51828, Q16760 | RAF1, AKT2, GAB2, PIP5K1B, PSCD1, ADCY1, ADCY7, DGKD | More | | Tofacitinib | hsa04080 | Neuroactive ligand-receptor interaction | 4.42E-06 | 12 | P08311, P78334, Q15722, P21453, Q9H228, P43657, O00398, P21462, P21730, P30939, P07550, P35318 | CTSG, GABRE, LTB4R, S1PR1, EDG8, P2RY5, P2RY10, FPR1, C5AR1, HTR1F, ADRB2, ADM | More | | Tofacitinib | hsa04110 | Cell cycle | 4.62E-07 | 12 | Q9UBD5, P30260, P06493, O60566, Q14683, P04637, P49918, P30304, P33981, P42773, P01106, Q13547 | ORC3, CDC27, CDK1, BUB1B, SMC1A, TP53, CDKN1C, CDC25A, TTK, CDKN2C, MYC, HDAC1 | More | | Tofacitinib | hsa04114 | Oocyte meiosis | 5.73E-10 | 11 | Q9Y6D9, P51812, Q02750, P0DP23, P16298, Q17RY0, Q08828, P51828, Q13362, Q14738, P08069 | MAD1L1, RPS6KA3, MAP2K1, CALM1, PPP3CB, CPEB4, ADCY1, ADCY7, PPP2R5C, PPP2R5D, IGF1R | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | Q9Y6D9 | MAD1L1 | Mitotic spindle assembly checkpoint protein MAD1 | -0.815 | Q05397 | PTK2 | Focal adhesion kinase 1 | Q9Y6D9 | MAD1L1 | Mitotic spindle assembly checkpoint protein MAD1 | -0.754 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | Q9Y6D9 | MAD1L1 | Mitotic spindle assembly checkpoint protein MAD1 | -0.764 | Q9HAZ1 | CLK4 | Dual specificity protein kinase CLK4 | Q9Y6D9 | MAD1L1 | Mitotic spindle assembly checkpoint protein MAD1 | -0.822 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | 1 | Q05397 | PTK2 | Focal adhesion kinase 1 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | 0.932 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | 0.93 | Q9HAZ1 | CLK4 | Dual specificity protein kinase CLK4 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | 0.922 | Q13873 | BMPR2 | Bone morphogenetic protein receptor type-2 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | 0.804 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.93 | Q05397 | PTK2 | Focal adhesion kinase 1 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.898 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 1 | Q9HAZ1 | CLK4 | Dual specificity protein kinase CLK4 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.911 | Q13873 | BMPR2 | Bone morphogenetic protein receptor type-2 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.852 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P0DP23 | CALM1 | Calmodulin-1 | 0.857 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.93 | Q05397 | PTK2 | Focal adhesion kinase 1 | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.919 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.927 | Q9HAZ1 | CLK4 | Dual specificity protein kinase CLK4 | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.861 | Q13873 | BMPR2 | Bone morphogenetic protein receptor type-2 | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.775 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | Q17RY0 | CPEB4 | Cytoplasmic polyadenylation element-binding protein 4 | 0.938 | Q05397 | PTK2 | Focal adhesion kinase 1 | Q17RY0 | CPEB4 | Cytoplasmic polyadenylation element-binding protein 4 | 0.909 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | Q17RY0 | CPEB4 | Cytoplasmic polyadenylation element-binding protein 4 | 0.859 | Q9HAZ1 | CLK4 | Dual specificity protein kinase CLK4 | Q17RY0 | CPEB4 | Cytoplasmic polyadenylation element-binding protein 4 | 0.92 | Q13873 | BMPR2 | Bone morphogenetic protein receptor type-2 | Q17RY0 | CPEB4 | Cytoplasmic polyadenylation element-binding protein 4 | 0.715 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.796 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.726 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | 0.735 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q14738 | PPP2R5D | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform | 0.781 | P08069 | IGF1R | Insulin-like growth factor 1 receptor | P08069 | IGF1R | Insulin-like growth factor 1 receptor | 1 |
| Tofacitinib | hsa04115 | p53 signaling pathway | 2.54E-02 | 3 | O15151, Q13315, P10415 | MDM4, ATM, BCL2 | More | | Tofacitinib | hsa04136 | Autophagy - other | 7.59E-03 | 2 | O94817, Q9H1Y0 | ATG12, ATG5 | More | | Tofacitinib | hsa04137 | Mitophagy - animal | 1.41E-03 | 3 | P67870, P19532, P18848 | CSNK2B, TFE3, ATF4 | More | | Tofacitinib | hsa04140 | Autophagy - animal | 5.46E-06 | 15 | P08069, Q9Y4H2, P42338, P31751, P04049, Q7L523, Q9NQL2, O75460, P22694, Q14643, P10415, Q9H1Y0, Q04759, Q96GC9, Q8TEV9 | IGF1R, IRS2, PIK3CB, AKT2, RAF1, RRAGA, RRAGD, ERN1, PRKACB, ITPR1, BCL2, ATG5, PRKCQ, TMEM49, SMCR8 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P08069 | IGF1R | Insulin-like growth factor 1 receptor | P08069 | IGF1R | Insulin-like growth factor 1 receptor | 1 | P24723 | PRKCH | Protein kinase C eta type | Q9Y4H2 | IRS2 | Insulin receptor substrate 2 | -0.716 | P24723 | PRKCH | Protein kinase C eta type | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.79 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.726 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q7L523 | RRAGA | Ras-related GTP-binding protein A | 0.796 | P24723 | PRKCH | Protein kinase C eta type | Q9NQL2 | RRAGD | Ras-related GTP-binding protein D | -0.701 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.734 | P42681 | TXK | Tyrosine-protein kinase TXK | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | 0.878 | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | 0.71 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | 0.873 | P42681 | TXK | Tyrosine-protein kinase TXK | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.926 | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.768 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.865 | P42681 | TXK | Tyrosine-protein kinase TXK | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.716 | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.723 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.744 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9H1Y0 | ATG5 | Autophagy protein 5 | 0.762 | P42681 | TXK | Tyrosine-protein kinase TXK | Q04759 | PRKCQ | Protein kinase C theta type | 0.876 | P24723 | PRKCH | Protein kinase C eta type | Q04759 | PRKCQ | Protein kinase C theta type | 0.791 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q04759 | PRKCQ | Protein kinase C theta type | 0.803 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q96GC9 | TMEM49 | Vacuole membrane protein 1 | 0.757 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q8TEV9 | SMCR8 | Guanine nucleotide exchange protein SMCR8 | 0.807 |
| Tofacitinib | hsa04141 | Protein processing in endoplasmic reticulum | 1.13E-04 | 12 | P18848, Q12933, P30101, Q15436, P60604, Q99941, P11142, Q9H3Z4, P07900, P08238, Q9NR31, Q9UNL2 | ATF4, TRAF2, PDIA3, SEC23A, UBE2G2, CREBL1, HSPA8, DNAJC5, HSP90AA1, HSP90AB1, SAR1A, SSR3 | More | | Tofacitinib | hsa04142 | Lysosome | 1.11E-05 | 11 | O14773, P06865, P22304, P38571, Q13510, Q9UJJ9, P07602, Q9NRA2, P49279, P61916, Q04900 | TPP1, HEXA, IDS, LIPA, ASAH1, GNPTG, PSAP, SLC17A5, SLC11A1, NPC2, CD164 | More | | Tofacitinib | hsa04144 | Endocytosis | 8.76E-07 | 19 | Q13191, P0DMV8, P11142, Q9H444, O43633, O75351, P62491, P25024, Q96B97, P43250, Q6WKZ4, Q15438, Q8WU79, Q14161, P14784, O95219, O75154, Q9UMY4, Q9Y5X3 | CBLB, HSPA1A, HSPA8, CHMP4B, CHMP2A, VPS4B, RAB11A, CXCR1, SH3KBP1, GRK6, RAB11FIP1, PSCD1, SMAP1L, GIT2, IL2RB, SNX4, RAB11FIP3, SNX12, SNX5 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P07948 | LYN | Tyrosine-protein kinase Lyn | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.717 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P0DMV8 | HSPA1A | Heat shock 70 kDa protein 1A | 0.753 | Q96RR4 | CAMKK2 | Calcium/calmodulin-dependent protein kinase kinase 2 | P0DMV8 | HSPA1A | Heat shock 70 kDa protein 1A | 0.81 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P0DMV8 | HSPA1A | Heat shock 70 kDa protein 1A | 0.753 | Q96RR4 | CAMKK2 | Calcium/calmodulin-dependent protein kinase kinase 2 | P0DMV8 | HSPA1A | Heat shock 70 kDa protein 1A | 0.81 | P07948 | LYN | Tyrosine-protein kinase Lyn | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.732 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.926 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q9H444 | CHMP4B | Charged multivesicular body protein 4b | 0.862 | Q96RR4 | CAMKK2 | Calcium/calmodulin-dependent protein kinase kinase 2 | Q9H444 | CHMP4B | Charged multivesicular body protein 4b | 0.722 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | O43633 | CHMP2A | Charged multivesicular body protein 2a | -0.777 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | O75351 | VPS4B | Vacuolar protein sorting-associated protein 4B | 0.707 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P62491 | RAB11A | Ras-related protein Rab-11A | 0.854 | Q96RR4 | CAMKK2 | Calcium/calmodulin-dependent protein kinase kinase 2 | P62491 | RAB11A | Ras-related protein Rab-11A | 0.822 | P07948 | LYN | Tyrosine-protein kinase Lyn | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | 0.707 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q96B97 | SH3KBP1 | SH3 domain-containing kinase-binding protein 1 | 0.716 | P07948 | LYN | Tyrosine-protein kinase Lyn | P43250 | GRK6 | G protein-coupled receptor kinase 6 | 0.764 | Q9Y6E0 | STK24 | Serine/threonine-protein kinase 24 | Q6WKZ4 | RAB11FIP1 | Rab11 family-interacting protein 1 | 0.769 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q15438 | PSCD1 | Cytohesin-1 | 0.756 | Q9Y6E0 | STK24 | Serine/threonine-protein kinase 24 | Q15438 | PSCD1 | Cytohesin-1 | 0.757 | Q96RR4 | CAMKK2 | Calcium/calmodulin-dependent protein kinase kinase 2 | Q8WU79 | SMAP1L | Stromal membrane-associated protein 2 | 0.781 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q14161 | GIT2 | ARF GTPase-activating protein GIT2 | 0.817 | Q9Y6E0 | STK24 | Serine/threonine-protein kinase 24 | Q14161 | GIT2 | ARF GTPase-activating protein GIT2 | 0.739 | Q96RR4 | CAMKK2 | Calcium/calmodulin-dependent protein kinase kinase 2 | Q14161 | GIT2 | ARF GTPase-activating protein GIT2 | 0.737 | P07948 | LYN | Tyrosine-protein kinase Lyn | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.771 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.736 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | O95219 | SNX4 | Sorting nexin-4 | 0.749 | Q9Y6E0 | STK24 | Serine/threonine-protein kinase 24 | O75154 | RAB11FIP3 | Rab11 family-interacting protein 3 | -0.706 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q9UMY4 | SNX12 | Sorting nexin-12 | 0.835 | Q96RR4 | CAMKK2 | Calcium/calmodulin-dependent protein kinase kinase 2 | Q9UMY4 | SNX12 | Sorting nexin-12 | 0.79 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q9Y5X3 | SNX5 | Sorting nexin-5 | -0.782 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | Q9Y5X3 | SNX5 | Sorting nexin-5 | -0.816 |
| Tofacitinib | hsa04145 | Phagosome | 4.29E-06 | 11 | O75015, Q15080, P14598, Q13509, P68371, Q13488, P05164, P78380, O60603, P35443, P13765 | FCGR3B, NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, MPO, OLR1, TLR2, THBS4, HLA-DOB | More | | Tofacitinib | hsa04146 | Peroxisome | 1.95E-03 | 6 | O00623, O96011, P56589, Q9UKG9, O75521, P33121 | PEX12, PEX11B, PEX3, CROT, ECI2, ACSL1 | More | | Tofacitinib | hsa04150 | mTOR signaling pathway | 5.20E-04 | 2 | P08069, P04049 | IGF1R, RAF1 | More | | Tofacitinib | hsa04151 | PI3K-Akt signaling pathway | 2.54E-07 | 27 | P62753, P21860, P25116, O43521, P04637, P27348, P49767, Q13362, P07900, P62873, P61952, P16144, P02452, P24821, Q16363, P22105, O60603, P23458, P01568, Q99941, P18848, P10415, P17252, Q96BR1, O00141, Q6ZUJ8, P56279 | RPS6, ERBB3, F2R, BCL2L11, TP53, YWHAQ, VEGFC, PPP2R5C, HSP90AA1, GNB1, GNG11, ITGB4, COL1A1, TNC, LAMA4, TNXB, TLR2, JAK1, IFNA21, CREBL1, ATF4, BCL2, PRKCA, SGK3, SGK, PIK3AP1, TCL1A | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P62753 | RPS6 | 40S ribosomal protein S6 | 0.716 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P62753 | RPS6 | 40S ribosomal protein S6 | 0.709 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | -0.85 | P17252 | PRKCA | Protein kinase C alpha type | P25116 | F2R | Proteinase-activated receptor 1 | 0.857 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | O43521 | BCL2L11 | Bcl-2-like protein 11 | 0.742 | Q9UEE5 | STK17A | Serine/threonine-protein kinase 17A | P04637 | TP53 | Cellular tumor antigen p53 | -0.831 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | P27348 | YWHAQ | 14-3-3 protein theta | 0.856 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P27348 | YWHAQ | 14-3-3 protein theta | 0.742 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P27348 | YWHAQ | 14-3-3 protein theta | 0.76 | P17252 | PRKCA | Protein kinase C alpha type | P49767 | VEGFC | Vascular endothelial growth factor C | 0.719 | P17252 | PRKCA | Protein kinase C alpha type | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | 0.745 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | 0.804 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 0.778 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 0.786 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 0.763 | P17252 | PRKCA | Protein kinase C alpha type | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.852 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.789 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P61952 | GNG11 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 | -0.756 | P17252 | PRKCA | Protein kinase C alpha type | P16144 | ITGB4 | Integrin beta-4 | 0.755 | P49760 | CLK2 | Dual specificity protein kinase CLK2 | P02452 | COL1A1 | Collagen alpha-1(I) chain | -0.776 | P49760 | CLK2 | Dual specificity protein kinase CLK2 | P24821 | TNC | Tenascin | -0.718 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | Q16363 | LAMA4 | Laminin subunit alpha-4 | 0.729 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | Q16363 | LAMA4 | Laminin subunit alpha-4 | 0.773 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | P22105 | TNXB | Tenascin-X | 0.774 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P22105 | TNXB | Tenascin-X | 0.72 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P22105 | TNXB | Tenascin-X | 0.801 | P17252 | PRKCA | Protein kinase C alpha type | O60603 | TLR2 | Toll-like receptor 2 | -0.716 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.762 | P17252 | PRKCA | Protein kinase C alpha type | P01568 | IFNA21 | Interferon alpha-21 | 0.733 | P49760 | CLK2 | Dual specificity protein kinase CLK2 | P01568 | IFNA21 | Interferon alpha-21 | -0.752 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.774 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.72 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.801 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.773 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.844 | P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 | P17252 | PRKCA | Protein kinase C alpha type | P17252 | PRKCA | Protein kinase C alpha type | 1 | Q9UEE5 | STK17A | Serine/threonine-protein kinase 17A | Q96BR1 | SGK3 | Serine/threonine-protein kinase Sgk3 | -0.804 | Q9UEE5 | STK17A | Serine/threonine-protein kinase 17A | Q96BR1 | SGK3 | Serine/threonine-protein kinase Sgk3 | -0.804 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | 0.788 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | Q6ZUJ8 | PIK3AP1 | Phosphoinositide 3-kinase adapter protein 1 | 0.736 | Q9UEE5 | STK17A | Serine/threonine-protein kinase 17A | P56279 | TCL1A | T-cell leukemia/lymphoma protein 1A | -0.824 |
| Tofacitinib | hsa04152 | AMPK signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | | Tofacitinib | hsa04210 | Apoptosis | 1.10E-03 | 4 | Q14790, P48023, P42575, P04049 | CASP8, FASLG, CASP2, RAF1 | More | | Tofacitinib | hsa04211 | Longevity regulating pathway | 2.60E-04 | 6 | P31751, P08069, Q08828, P51828, P18848, Q96RR4 | AKT2, IGF1R, ADCY1, ADCY7, ATF4, CAMKK2 | More | | Tofacitinib | hsa04213 | Longevity regulating pathway - multiple species | 1.23E-07 | 9 | P31751, P42338, P08069, Q9Y4H2, Q08828, P51828, P0DMV8, P11142, Q13547 | AKT2, PIK3CB, IGF1R, IRS2, ADCY1, ADCY7, HSPA1A, HSPA8, HDAC1 | More | | Tofacitinib | hsa04217 | Necroptosis | 1.39E-12 | 20 | Q12933, P01568, P23458, Q13489, Q9NQC7, Q13546, P42224, P07900, P15104, P05141, P01584, P0C0S5, Q6FI13, P10415, Q13557, Q9H444, O43633, O75351, P45880, Q08752 | TRAF2, IFNA21, JAK1, BIRC3, CYLD, RIPK1, STAT1, HSP90AA1, GLUL, SLC25A5, IL1B, H2AFZ, H2AC18; H2AC19, BCL2, CAMK2D, CHMP4B, CHMP2A, VPS4B, VDAC2, PPID | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | Q12933 | TRAF2 | TNF receptor-associated factor 2 | 0.802 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | P01568 | IFNA21 | Interferon alpha-21 | -0.813 | P17252 | PRKCA | Protein kinase C alpha type | P01568 | IFNA21 | Interferon alpha-21 | 0.733 | P49760 | CLK2 | Dual specificity protein kinase CLK2 | P01568 | IFNA21 | Interferon alpha-21 | -0.752 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.762 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.79 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.788 | P17252 | PRKCA | Protein kinase C alpha type | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.849 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.749 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.733 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.794 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | 1 | P49760 | CLK2 | Dual specificity protein kinase CLK2 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | 0.741 | P17252 | PRKCA | Protein kinase C alpha type | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.706 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 0.709 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 0.778 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 0.786 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 0.763 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | P15104 | GLUL | Glutamine synthetase | 0.761 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P15104 | GLUL | Glutamine synthetase | 0.809 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.716 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.778 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.779 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | P01584 | IL1B | Interleukin-1 beta | 0.786 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | P01584 | IL1B | Interleukin-1 beta | 0.834 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | P01584 | IL1B | Interleukin-1 beta | 0.826 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P01584 | IL1B | Interleukin-1 beta | 0.725 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | P0C0S5 | H2AFZ | Histone H2A.Z | 0.73 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P0C0S5 | H2AFZ | Histone H2A.Z | 0.786 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.751 | P17252 | PRKCA | Protein kinase C alpha type | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | -0.83 | P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.7 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.741 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 1 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | Q9H444 | CHMP4B | Charged multivesicular body protein 4b | 0.717 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | Q9H444 | CHMP4B | Charged multivesicular body protein 4b | 0.774 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | Q9H444 | CHMP4B | Charged multivesicular body protein 4b | 0.842 | P17252 | PRKCA | Protein kinase C alpha type | O43633 | CHMP2A | Charged multivesicular body protein 2a | -0.836 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | O75351 | VPS4B | Vacuolar protein sorting-associated protein 4B | 0.715 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | O75351 | VPS4B | Vacuolar protein sorting-associated protein 4B | 0.886 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | P45880 | VDAC2 | Voltage-dependent anion-selective channel protein 2 | 0.748 | P17252 | PRKCA | Protein kinase C alpha type | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | 0.725 |
| Tofacitinib | hsa04218 | Cellular senescence | 1.96E-04 | 7 | P31751, P04049, P30281, P0DP23, P01889, P10321, P12236 | AKT2, RAF1, CCND3, CALM1, HLA-B, HLA-C, SLC25A6 | More | | Tofacitinib | hsa04260 | Cardiac muscle contraction | 4.20E-02 | 3 | P67936, P13073, P12074 | TPM4, COX4I1, COX6A1 | More | | Tofacitinib | hsa04261 | Adrenergic signaling in cardiomyocytes | 6.80E-09 | 15 | P09493, P67936, Q08828, P51828, P31751, Q99941, P18848, Q13362, Q14738, P0DP23, P0DP24, Q13557, P17252, P10415, P23634 | TPM1, TPM4, ADCY1, ADCY7, AKT2, CREBL1, ATF4, PPP2R5C, PPP2R5D, CALM1, CALM2, CAMK2D, PRKCA, BCL2, ATP2B4 | More | | Tofacitinib | hsa04270 | Vascular smooth muscle contraction | 1.71E-06 | 11 | P24723, Q04759, Q14643, P0DP23, P04049, Q08828, P51828, P22694, P35579, P35749, P35318 | PRKCH, PRKCQ, ITPR1, CALM1, RAF1, ADCY1, ADCY7, PRKACB, MYH9, MYH11, ADM | More | | Tofacitinib | hsa04310 | Wnt signaling pathway | 2.28E-04 | 5 | P30279, Q13485, O43318, P17612, P67870 | CCND2, SMAD4, MAP3K7, PRKACA, CSNK2B | More | | Tofacitinib | hsa04330 | Notch signaling pathway | 4.54E-04 | 4 | Q92542, P49768, P46531, Q9UM47 | NCSTN, PSEN1, NOTCH1, NOTCH3 | More | | Tofacitinib | hsa04340 | Hedgehog signaling pathway | 6.09E-05 | 4 | P17612, P22694, Q13635, P10415 | PRKACA, PRKACB, PTCH1, BCL2 | More | | Tofacitinib | hsa04360 | Axon guidance | 2.95E-05 | 10 | P16298, Q05397, P20827, O95631, Q13873, P42338, P23528, P04049, O14639, P24844 | PPP3CB, PTK2, EFNA1, NTN1, BMPR2, PIK3CB, CFL1, RAF1, ABLIM1, MYL9 | More | | Tofacitinib | hsa04370 | VEGF signaling pathway | 6.18E-13 | 7 | P19174, P16298, P31751, P42338, Q05397, Q02750, P04049 | PLCG1, PPP3CB, AKT2, PIK3CB, PTK2, MAP2K1, RAF1 | More | | Tofacitinib | hsa04371 | Apelin signaling pathway | 1.43E-04 | 9 | P62873, P61952, P31751, P04049, Q08828, P51828, P62753, P0DP23, P0DP24 | GNB1, GNG11, AKT2, RAF1, ADCY1, ADCY7, RPS6, CALM1, CALM2 | More | | Tofacitinib | hsa04380 | Osteoclast differentiation | 2.25E-07 | 10 | Q9NQC7, Q9UQC2, Q16539, P23458, P31751, P01584, P14778, O75015, P01375, Q8N149 | CYLD, GAB2, MAPK14, JAK1, AKT2, IL1B, IL1R1, FCGR3B, TNF, LILRA2 | More | | Tofacitinib | hsa04390 | Hippo signaling pathway | 3.37E-05 | 5 | O95835, P04628, Q9UJU2, O43623, Q13489 | LATS1, WNT1, LEF1, SNAI2, BIRC3 | More | | Tofacitinib | hsa04392 | Hippo signaling pathway - multiple species | 2.11E-05 | 3 | O95835, Q13153, Q6V0I7 | LATS1, PAK1, FAT4 | More | | Tofacitinib | hsa04510 | Focal adhesion | 1.63E-03 | 5 | Q15942, P51636, P30281, P04049, P08069 | ZYX, CAV2, CCND3, RAF1, IGF1R | More | | Tofacitinib | hsa04512 | ECM-receptor interaction | 2.77E-05 | 6 | P02452, P24821, P07359, P26012, P08514, P16070 | COL1A1, TNC, GP1BA, ITGB8, ITGA2B, CD44 | More | | Tofacitinib | hsa04520 | Adherens junction | 1.81E-03 | 3 | Q13485, O43318, P08069 | SMAD4, MAP3K7, IGF1R | More | | Tofacitinib | hsa04540 | Gap junction | 5.58E-06 | 7 | P17252, P22694, Q13509, P68371, P04049, Q9NRA1, Q14643 | PRKCA, PRKACB, TUBB3, TUBB2C, RAF1, PDGFC, ITPR1 | More | | Tofacitinib | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 1.61E-03 | 5 | Q13873, P04049, Q02750, P08069, Q86SE9 | BMPR2, RAF1, MAP2K1, IGF1R, PCGF5 | More | | Tofacitinib | hsa04610 | Complement and coagulation cascades | 1.45E-08 | 4 | P09871, P0C0L4, P20023, P05107 | C1S, C4A, CR2, ITGB2 | More | | Tofacitinib | hsa04611 | Platelet activation | 2.65E-05 | 6 | Q9Y490, P08514, Q15746, Q8WYR1, P17612, P07359 | TLN1, ITGA2B, MYLK, PIK3R5, PRKACA, GP1BA | More | | Tofacitinib | hsa04612 | Antigen processing and presentation | 1.36E-08 | 11 | P13765, P48382, P01730, P26715, P26717, Q07444, Q13241, P01732, P30101, P11142, P01375 | HLA-DOB, RFX5, CD4, KLRC1, KLRC2, KLRC3, KLRD1, CD8A, PDIA3, HSPA8, TNF | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q04759 | PRKCQ | Protein kinase C theta type | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.82 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.76 | P06239 | LCK | Tyrosine-protein kinase Lck | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.777 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.85 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.734 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P48382 | RFX5 | DNA-binding protein RFX5 | 0.726 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P48382 | RFX5 | DNA-binding protein RFX5 | 0.826 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | Q04759 | PRKCQ | Protein kinase C theta type | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.803 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.972 | P06239 | LCK | Tyrosine-protein kinase Lck | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.756 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.943 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.915 | Q04759 | PRKCQ | Protein kinase C theta type | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.803 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.972 | P06239 | LCK | Tyrosine-protein kinase Lck | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.756 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.943 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.915 | P24723 | PRKCH | Protein kinase C eta type | Q07444 | KLRC3 | NKG2-E type II integral membrane protein | 0.723 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q07444 | KLRC3 | NKG2-E type II integral membrane protein | 0.718 | Q04759 | PRKCQ | Protein kinase C theta type | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.849 | P24723 | PRKCH | Protein kinase C eta type | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.768 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.883 | P06239 | LCK | Tyrosine-protein kinase Lck | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.758 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.852 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.941 | Q04759 | PRKCQ | Protein kinase C theta type | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.861 | P24723 | PRKCH | Protein kinase C eta type | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.838 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.812 | P06239 | LCK | Tyrosine-protein kinase Lck | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.841 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.803 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.892 | P24723 | PRKCH | Protein kinase C eta type | P30101 | PDIA3 | Protein disulfide-isomerase A3 | 0.751 | P24723 | PRKCH | Protein kinase C eta type | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.715 | Q04759 | PRKCQ | Protein kinase C theta type | P01375 | TNF | Tumor necrosis factor | -0.725 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P01375 | TNF | Tumor necrosis factor | -0.813 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P01375 | TNF | Tumor necrosis factor | -0.783 |
| Tofacitinib | hsa04613 | Neutrophil extracellular trap formation | 1.15E-06 | 25 | P19174, P17252, P04049, P16109, P11215, O60603, P05164, P08246, Q9UM07, Q13547, Q6FI13, Q99878, P62807, Q16778, P68431, P14598, Q15080, P20160, P08311, P49913, O75015, P21730, P08514, P21462, P07359 | PLCG1, PRKCA, RAF1, SELP, ITGAM, TLR2, MPO, ELA2, PADI4, HDAC1, H2AC18; H2AC19, H2AC14, HIST1H2BC, HIST2H2BE, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF1, NCF4, AZU1, CTSG, CAMP, FCGR3B, C5AR1, ITGA2B, FPR1, GP1BA | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.785 | P17252 | PRKCA | Protein kinase C alpha type | P17252 | PRKCA | Protein kinase C alpha type | 1 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | Q15746 | MYLK | Myosin light chain kinase, smooth muscle | P16109 | SELP | P-selectin | 0.776 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | P11215 | ITGAM | Integrin alpha-M | 0.795 | P17252 | PRKCA | Protein kinase C alpha type | O60603 | TLR2 | Toll-like receptor 2 | -0.716 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P05164 | MPO | Myeloperoxidase | -0.817 | P17252 | PRKCA | Protein kinase C alpha type | P08246 | ELA2 | Neutrophil elastase | -0.735 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P08246 | ELA2 | Neutrophil elastase | -0.772 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | -0.809 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | Q13547 | HDAC1 | Histone deacetylase 1 | -0.731 | P17252 | PRKCA | Protein kinase C alpha type | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | -0.83 | Q15746 | MYLK | Myosin light chain kinase, smooth muscle | Q99878 | H2AC14 | Histone H2A type 1-J | 0.76 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.702 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.702 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | Q16778 | HIST2H2BE | Histone H2B type 2-E | 0.728 | P17252 | PRKCA | Protein kinase C alpha type | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | 0.783 | P17252 | PRKCA | Protein kinase C alpha type | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.821 | P17252 | PRKCA | Protein kinase C alpha type | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.836 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.742 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P20160 | AZU1 | Azurocidin | -0.771 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P08311 | CTSG | Cathepsin G | -0.847 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P49913 | CAMP | Cathelicidin antimicrobial peptide | -0.722 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | -0.704 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | -0.779 | Q15746 | MYLK | Myosin light chain kinase, smooth muscle | P08514 | ITGA2B | Integrin alpha-IIb | 0.812 | P17252 | PRKCA | Protein kinase C alpha type | P21462 | FPR1 | fMet-Leu-Phe receptor | -0.731 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P21462 | FPR1 | fMet-Leu-Phe receptor | -0.737 | Q15746 | MYLK | Myosin light chain kinase, smooth muscle | P07359 | GP1BA | Platelet glycoprotein Ib alpha chain | 0.814 |
| Tofacitinib | hsa04620 | Toll-like receptor signaling pathway | 2.48E-05 | 5 | Q13546, P01568, P01584, P31751, Q8NHW4 | RIPK1, IFNA21, IL1B, AKT2, CCL4L2 | More | | Tofacitinib | hsa04621 | NOD-like receptor signaling pathway | 1.92E-04 | 12 | P01584, P07900, Q14643, P23458, P45880, P10599, P43490, O00463, P29728, P01375, P09341, P12838 | IL1B, HSP90AA1, ITPR1, JAK1, VDAC2, TXN, PBEF1, TRAF5, OAS2, TNF, CXCL1, DEFA4 | More | | Tofacitinib | hsa04622 | RIG-I-like receptor signaling pathway | 1.29E-07 | 5 | P01568, Q9NQC7, Q13546, Q12933, P10145 | IFNA21, CYLD, RIPK1, TRAF2, IL8 | More | | Tofacitinib | hsa04623 | Cytosolic DNA-sensing pathway | 1.82E-10 | 5 | P01584, P01568, Q13546, Q9Y535, Q8NHW4 | IL1B, IFNA21, RIPK1, POLR3H, CCL4L2 | More | | Tofacitinib | hsa04625 | C-type lectin receptor signaling pathway | 4.61E-08 | 10 | Q9ULY5, P04049, Q13153, P01584, Q9NQC7, P20749, P01375, P31751, P0DP23, Q16539 | CLEC4E, RAF1, PAK1, IL1B, CYLD, BCL3, TNF, AKT2, CALM1, MAPK14 | More | | Tofacitinib | hsa04630 | JAK-STAT signaling pathway | 1.01E-04 | 8 | P01106, P31751, P42224, P23458, P14784, P16871, Q13651, P04049 | MYC, AKT2, STAT1, JAK1, IL2RB, IL7R, IL10RA, RAF1 | More | | Tofacitinib | hsa04640 | Hematopoietic cell lineage | 7.44E-10 | 17 | P13612, P07359, P08514, P14778, P27930, P11215, P15144, P20023, P25063, P07766, P09693, P01732, P01730, P06127, P09564, P13765, P01375 | ITGA4, GP1BA, ITGA2B, IL1R1, IL1R2, ITGAM, ANPEP, CR2, CD24, CD3E, CD3G, CD8A, CD4, CD5, CD7, HLA-DOB, TNF | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P06239 | LCK | Tyrosine-protein kinase Lck | P13612 | ITGA4 | Integrin alpha-4 | 0.732 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13612 | ITGA4 | Integrin alpha-4 | 0.774 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P13612 | ITGA4 | Integrin alpha-4 | 0.735 | Q15746 | MYLK | Myosin light chain kinase, smooth muscle | P07359 | GP1BA | Platelet glycoprotein Ib alpha chain | 0.814 | Q15746 | MYLK | Myosin light chain kinase, smooth muscle | P08514 | ITGA2B | Integrin alpha-IIb | 0.812 | P24723 | PRKCH | Protein kinase C eta type | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.705 | P06239 | LCK | Tyrosine-protein kinase Lck | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.782 | Q04759 | PRKCQ | Protein kinase C theta type | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.733 | P06239 | LCK | Tyrosine-protein kinase Lck | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.779 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.727 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.813 | P24723 | PRKCH | Protein kinase C eta type | P11215 | ITGAM | Integrin alpha-M | -0.7 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P15144 | ANPEP | Aminopeptidase N | -0.757 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P15144 | ANPEP | Aminopeptidase N | -0.765 | Q15746 | MYLK | Myosin light chain kinase, smooth muscle | P20023 | CR2 | Complement receptor type 2 | 0.727 | Q04759 | PRKCQ | Protein kinase C theta type | P25063 | CD24 | Signal transducer CD24 | -0.903 | P24723 | PRKCH | Protein kinase C eta type | P25063 | CD24 | Signal transducer CD24 | -0.838 | P06239 | LCK | Tyrosine-protein kinase Lck | P25063 | CD24 | Signal transducer CD24 | -0.779 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P25063 | CD24 | Signal transducer CD24 | -0.839 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P25063 | CD24 | Signal transducer CD24 | -0.838 | Q04759 | PRKCQ | Protein kinase C theta type | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.713 | P24723 | PRKCH | Protein kinase C eta type | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.887 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | Q04759 | PRKCQ | Protein kinase C theta type | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.756 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.813 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.731 | Q04759 | PRKCQ | Protein kinase C theta type | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.861 | P24723 | PRKCH | Protein kinase C eta type | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.838 | P06239 | LCK | Tyrosine-protein kinase Lck | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.841 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.803 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.892 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | P06493 | CDK1 | Cyclin-dependent kinase 1 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.732 | P06493 | CDK1 | Cyclin-dependent kinase 1 | P06127 | CD5 | T-cell surface glycoprotein CD5 | -0.739 | P24723 | PRKCH | Protein kinase C eta type | P09564 | CD7 | T-cell antigen CD7 | 0.865 | P06239 | LCK | Tyrosine-protein kinase Lck | P09564 | CD7 | T-cell antigen CD7 | 0.84 | P06493 | CDK1 | Cyclin-dependent kinase 1 | P09564 | CD7 | T-cell antigen CD7 | -0.735 | Q04759 | PRKCQ | Protein kinase C theta type | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.82 | P06239 | LCK | Tyrosine-protein kinase Lck | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.777 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.85 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.734 | Q04759 | PRKCQ | Protein kinase C theta type | P01375 | TNF | Tumor necrosis factor | -0.725 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P01375 | TNF | Tumor necrosis factor | -0.783 |
| Tofacitinib | hsa04650 | Natural killer cell mediated cytotoxicity | 3.34E-18 | 18 | P16298, P50591, P19174, P01375, P06239, O60880, P20963, P42338, Q02750, P04049, Q13153, Q13241, P26718, O14931, O75015, P26717, Q07444, P26715 | PPP3CB, TNFSF10, PLCG1, TNF, LCK, SH2D1A, CD247, PIK3CB, MAP2K1, RAF1, PAK1, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KLRC3, KLRC1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q05397 | PTK2 | Focal adhesion kinase 1 | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.919 | Q05397 | PTK2 | Focal adhesion kinase 1 | P50591 | TNFSF10 | Tumor necrosis factor ligand superfamily member 10 | 0.849 | P24723 | PRKCH | Protein kinase C eta type | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.767 | Q04759 | PRKCQ | Protein kinase C theta type | P01375 | TNF | Tumor necrosis factor | -0.725 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P01375 | TNF | Tumor necrosis factor | -0.813 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P01375 | TNF | Tumor necrosis factor | -0.783 | P42681 | TXK | Tyrosine-protein kinase TXK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.734 | Q04759 | PRKCQ | Protein kinase C theta type | P06239 | LCK | Tyrosine-protein kinase Lck | 0.779 | P24723 | PRKCH | Protein kinase C eta type | P06239 | LCK | Tyrosine-protein kinase Lck | 0.912 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.769 | P42681 | TXK | Tyrosine-protein kinase TXK | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.881 | Q04759 | PRKCQ | Protein kinase C theta type | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.855 | P24723 | PRKCH | Protein kinase C eta type | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.835 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.912 | P06239 | LCK | Tyrosine-protein kinase Lck | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.906 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.862 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.922 | P42681 | TXK | Tyrosine-protein kinase TXK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.811 | Q04759 | PRKCQ | Protein kinase C theta type | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.92 | P24723 | PRKCH | Protein kinase C eta type | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.939 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.776 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.839 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.881 | P24723 | PRKCH | Protein kinase C eta type | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.79 | Q05397 | PTK2 | Focal adhesion kinase 1 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.898 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | Q13153 | PAK1 | Serine/threonine-protein kinase PAK 1 | Q13153 | PAK1 | Serine/threonine-protein kinase PAK 1 | 1 | P42681 | TXK | Tyrosine-protein kinase TXK | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.888 | Q04759 | PRKCQ | Protein kinase C theta type | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.849 | P24723 | PRKCH | Protein kinase C eta type | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.768 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.883 | P06239 | LCK | Tyrosine-protein kinase Lck | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.758 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.852 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.941 | P42681 | TXK | Tyrosine-protein kinase TXK | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.869 | Q04759 | PRKCQ | Protein kinase C theta type | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.918 | P24723 | PRKCH | Protein kinase C eta type | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.822 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.794 | P06239 | LCK | Tyrosine-protein kinase Lck | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.886 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.922 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.858 | P24723 | PRKCH | Protein kinase C eta type | O14931 | NCR3 | Natural cytotoxicity triggering receptor 3 | 0.828 | P06239 | LCK | Tyrosine-protein kinase Lck | O14931 | NCR3 | Natural cytotoxicity triggering receptor 3 | 0.732 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | -0.704 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | -0.778 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | -0.716 | P42681 | TXK | Tyrosine-protein kinase TXK | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.901 | Q04759 | PRKCQ | Protein kinase C theta type | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.803 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.972 | P06239 | LCK | Tyrosine-protein kinase Lck | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.756 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.943 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.915 | P24723 | PRKCH | Protein kinase C eta type | Q07444 | KLRC3 | NKG2-E type II integral membrane protein | 0.723 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q07444 | KLRC3 | NKG2-E type II integral membrane protein | 0.718 | P42681 | TXK | Tyrosine-protein kinase TXK | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.901 | Q04759 | PRKCQ | Protein kinase C theta type | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.803 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.972 | P06239 | LCK | Tyrosine-protein kinase Lck | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.756 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.943 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.915 |
| Tofacitinib | hsa04657 | IL-17 signaling pathway | 2.96E-07 | 14 | P25963, P07900, P08238, O00463, Q12933, Q07955, Q16539, P49841, P09341, P14780, P80188, P01375, P06702, P01584 | NFKBIA, HSP90AA1, HSP90AB1, TRAF5, TRAF2, SFRS1, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF, S100A9, IL1B | More | | Tofacitinib | hsa04658 | Th1 and Th2 cell differentiation | 3.25E-29 | 17 | P25963, Q04759, P07766, P20963, P09693, Q16539, P19174, P01730, P06239, P42224, Q14765, P23771, Q9UL17, P14784, Q9UM47, P13765, Q13761 | NFKBIA, PRKCQ, CD3E, CD247, CD3G, MAPK14, PLCG1, CD4, LCK, STAT1, STAT4, GATA3, TBX21, IL2RB, NOTCH3, HLA-DOB, RUNX3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.789 | P42681 | TXK | Tyrosine-protein kinase TXK | Q04759 | PRKCQ | Protein kinase C theta type | 0.876 | Q04759 | PRKCQ | Protein kinase C theta type | Q04759 | PRKCQ | Protein kinase C theta type | 1 | P24723 | PRKCH | Protein kinase C eta type | Q04759 | PRKCQ | Protein kinase C theta type | 0.791 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q04759 | PRKCQ | Protein kinase C theta type | 0.755 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q04759 | PRKCQ | Protein kinase C theta type | 0.803 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q04759 | PRKCQ | Protein kinase C theta type | 0.869 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q04759 | PRKCQ | Protein kinase C theta type | -0.737 | Q04759 | PRKCQ | Protein kinase C theta type | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.713 | P24723 | PRKCH | Protein kinase C eta type | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.887 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.779 | P07948 | LYN | Tyrosine-protein kinase Lyn | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.824 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.755 | P42681 | TXK | Tyrosine-protein kinase TXK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.811 | Q04759 | PRKCQ | Protein kinase C theta type | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.92 | P24723 | PRKCH | Protein kinase C eta type | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.939 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.776 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.839 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.881 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.778 | P42681 | TXK | Tyrosine-protein kinase TXK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.838 | Q04759 | PRKCQ | Protein kinase C theta type | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.756 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.813 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.731 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.802 | P24723 | PRKCH | Protein kinase C eta type | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.767 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.785 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.888 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.857 | P42681 | TXK | Tyrosine-protein kinase TXK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.734 | Q04759 | PRKCQ | Protein kinase C theta type | P06239 | LCK | Tyrosine-protein kinase Lck | 0.779 | P24723 | PRKCH | Protein kinase C eta type | P06239 | LCK | Tyrosine-protein kinase Lck | 0.912 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.827 | P07948 | LYN | Tyrosine-protein kinase Lyn | P06239 | LCK | Tyrosine-protein kinase Lck | -0.701 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.769 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P06239 | LCK | Tyrosine-protein kinase Lck | -0.791 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.723 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.77 | P42681 | TXK | Tyrosine-protein kinase TXK | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.771 | Q04759 | PRKCQ | Protein kinase C theta type | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.746 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.928 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.904 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.821 | P42681 | TXK | Tyrosine-protein kinase TXK | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.856 | Q04759 | PRKCQ | Protein kinase C theta type | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.867 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.715 | P06239 | LCK | Tyrosine-protein kinase Lck | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.77 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.784 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.878 | P42681 | TXK | Tyrosine-protein kinase TXK | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.849 | Q04759 | PRKCQ | Protein kinase C theta type | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.843 | P24723 | PRKCH | Protein kinase C eta type | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.856 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.852 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.719 | P06239 | LCK | Tyrosine-protein kinase Lck | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.866 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.884 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.858 | P24723 | PRKCH | Protein kinase C eta type | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.876 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.788 | P07948 | LYN | Tyrosine-protein kinase Lyn | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.771 | P06239 | LCK | Tyrosine-protein kinase Lck | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.727 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.736 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | Q9UM47 | NOTCH3 | Neurogenic locus notch homolog protein 3 | -0.719 | P42681 | TXK | Tyrosine-protein kinase TXK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.89 | Q04759 | PRKCQ | Protein kinase C theta type | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.82 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.76 | P06239 | LCK | Tyrosine-protein kinase Lck | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.777 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.85 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.734 | P24723 | PRKCH | Protein kinase C eta type | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.915 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | Q13761 | RUNX3 | Runt-related transcription factor 3 | -0.713 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13761 | RUNX3 | Runt-related transcription factor 3 | -0.855 | P06239 | LCK | Tyrosine-protein kinase Lck | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.85 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.702 |
| Tofacitinib | hsa04659 | Th17 cell differentiation | 5.71E-22 | 19 | P25963, Q04759, Q16539, P19174, P01730, P06239, P42224, P14784, P13765, P14778, Q9HBE5, P40189, Q9UL17, P23771, Q13485, P08238, P07766, P09693, P20963 | NFKBIA, PRKCQ, MAPK14, PLCG1, CD4, LCK, STAT1, IL2RB, HLA-DOB, IL1R1, IL21R, IL6ST, TBX21, GATA3, SMAD4, HSP90AB1, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.789 | P42681 | TXK | Tyrosine-protein kinase TXK | Q04759 | PRKCQ | Protein kinase C theta type | 0.876 | Q04759 | PRKCQ | Protein kinase C theta type | Q04759 | PRKCQ | Protein kinase C theta type | 1 | P24723 | PRKCH | Protein kinase C eta type | Q04759 | PRKCQ | Protein kinase C theta type | 0.791 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q04759 | PRKCQ | Protein kinase C theta type | 0.803 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q04759 | PRKCQ | Protein kinase C theta type | 0.869 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q04759 | PRKCQ | Protein kinase C theta type | -0.737 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.802 | P24723 | PRKCH | Protein kinase C eta type | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.767 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.785 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.888 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.857 | P42681 | TXK | Tyrosine-protein kinase TXK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.734 | Q04759 | PRKCQ | Protein kinase C theta type | P06239 | LCK | Tyrosine-protein kinase Lck | 0.779 | P24723 | PRKCH | Protein kinase C eta type | P06239 | LCK | Tyrosine-protein kinase Lck | 0.912 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.827 | P07948 | LYN | Tyrosine-protein kinase Lyn | P06239 | LCK | Tyrosine-protein kinase Lck | -0.701 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.769 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P06239 | LCK | Tyrosine-protein kinase Lck | -0.791 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.723 | P29375 | JARID1A | Lysine-specific demethylase 5A | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.764 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.77 | P24723 | PRKCH | Protein kinase C eta type | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.876 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.788 | P07948 | LYN | Tyrosine-protein kinase Lyn | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.771 | P06239 | LCK | Tyrosine-protein kinase Lck | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.727 | P29375 | JARID1A | Lysine-specific demethylase 5A | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.768 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.736 | P42681 | TXK | Tyrosine-protein kinase TXK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.89 | Q04759 | PRKCQ | Protein kinase C theta type | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.82 | P06239 | LCK | Tyrosine-protein kinase Lck | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.777 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.85 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.734 | P24723 | PRKCH | Protein kinase C eta type | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.705 | P07948 | LYN | Tyrosine-protein kinase Lyn | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.714 | P06239 | LCK | Tyrosine-protein kinase Lck | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.782 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.854 | Q04759 | PRKCQ | Protein kinase C theta type | Q9HBE5 | IL21R | Interleukin-21 receptor | 0.8 | P24723 | PRKCH | Protein kinase C eta type | Q9HBE5 | IL21R | Interleukin-21 receptor | 0.776 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9HBE5 | IL21R | Interleukin-21 receptor | 0.713 | P29375 | JARID1A | Lysine-specific demethylase 5A | P40189 | IL6ST | Interleukin-6 receptor subunit beta | 0.83 | P42681 | TXK | Tyrosine-protein kinase TXK | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.849 | Q04759 | PRKCQ | Protein kinase C theta type | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.843 | P24723 | PRKCH | Protein kinase C eta type | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.856 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.719 | P06239 | LCK | Tyrosine-protein kinase Lck | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.866 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.884 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.858 | P42681 | TXK | Tyrosine-protein kinase TXK | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.856 | Q04759 | PRKCQ | Protein kinase C theta type | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.867 | P06239 | LCK | Tyrosine-protein kinase Lck | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.77 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.784 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.878 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.729 | P07948 | LYN | Tyrosine-protein kinase Lyn | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.782 | P29375 | JARID1A | Lysine-specific demethylase 5A | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.711 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.833 | Q04759 | PRKCQ | Protein kinase C theta type | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.713 | P24723 | PRKCH | Protein kinase C eta type | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.887 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.779 | P07948 | LYN | Tyrosine-protein kinase Lyn | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.824 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.755 | P42681 | TXK | Tyrosine-protein kinase TXK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.838 | Q04759 | PRKCQ | Protein kinase C theta type | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.756 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.813 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.731 | P42681 | TXK | Tyrosine-protein kinase TXK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.811 | Q04759 | PRKCQ | Protein kinase C theta type | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.92 | P24723 | PRKCH | Protein kinase C eta type | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.939 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.839 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.881 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.778 |
| Tofacitinib | hsa04660 | T cell receptor signaling pathway | 7.03E-20 | 19 | P01375, Q9UDY8, Q04759, P42338, P10747, O95267, Q08881, P19174, Q13153, P07766, P20963, P09693, P01730, P01732, Q13191, P06239, P04049, Q16539, P49841 | TNF, MALT1, PRKCQ, PIK3CB, CD28, RASGRP1, ITK, PLCG1, PAK1, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK, RAF1, MAPK14, GSK3B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q04759 | PRKCQ | Protein kinase C theta type | P01375 | TNF | Tumor necrosis factor | -0.725 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P01375 | TNF | Tumor necrosis factor | -0.813 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P01375 | TNF | Tumor necrosis factor | -0.783 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.721 | P42681 | TXK | Tyrosine-protein kinase TXK | Q04759 | PRKCQ | Protein kinase C theta type | 0.876 | Q04759 | PRKCQ | Protein kinase C theta type | Q04759 | PRKCQ | Protein kinase C theta type | 1 | P24723 | PRKCH | Protein kinase C eta type | Q04759 | PRKCQ | Protein kinase C theta type | 0.791 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q04759 | PRKCQ | Protein kinase C theta type | 0.755 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q04759 | PRKCQ | Protein kinase C theta type | 0.803 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q04759 | PRKCQ | Protein kinase C theta type | 0.869 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q04759 | PRKCQ | Protein kinase C theta type | -0.737 | P24723 | PRKCH | Protein kinase C eta type | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.79 | P42681 | TXK | Tyrosine-protein kinase TXK | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.776 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.79 | P42681 | TXK | Tyrosine-protein kinase TXK | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.857 | Q04759 | PRKCQ | Protein kinase C theta type | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.733 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.754 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.925 | P42681 | TXK | Tyrosine-protein kinase TXK | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.847 | Q04759 | PRKCQ | Protein kinase C theta type | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.803 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.873 | P06239 | LCK | Tyrosine-protein kinase Lck | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.774 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 1 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.808 | P24723 | PRKCH | Protein kinase C eta type | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.767 | Q13153 | PAK1 | Serine/threonine-protein kinase PAK 1 | Q13153 | PAK1 | Serine/threonine-protein kinase PAK 1 | 1 | Q04759 | PRKCQ | Protein kinase C theta type | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.713 | P24723 | PRKCH | Protein kinase C eta type | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.887 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.755 | P42681 | TXK | Tyrosine-protein kinase TXK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.811 | Q04759 | PRKCQ | Protein kinase C theta type | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.92 | P24723 | PRKCH | Protein kinase C eta type | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.939 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.776 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.839 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.881 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.778 | P42681 | TXK | Tyrosine-protein kinase TXK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.838 | Q04759 | PRKCQ | Protein kinase C theta type | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.756 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.813 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.731 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.857 | P42681 | TXK | Tyrosine-protein kinase TXK | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.9 | Q04759 | PRKCQ | Protein kinase C theta type | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.861 | P24723 | PRKCH | Protein kinase C eta type | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.838 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.812 | P06239 | LCK | Tyrosine-protein kinase Lck | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.841 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.803 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.892 | P42681 | TXK | Tyrosine-protein kinase TXK | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.716 | Q04759 | PRKCQ | Protein kinase C theta type | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.767 | P24723 | PRKCH | Protein kinase C eta type | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.779 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.734 | P06239 | LCK | Tyrosine-protein kinase Lck | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.714 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.811 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.795 | P42681 | TXK | Tyrosine-protein kinase TXK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.734 | Q04759 | PRKCQ | Protein kinase C theta type | P06239 | LCK | Tyrosine-protein kinase Lck | 0.779 | P24723 | PRKCH | Protein kinase C eta type | P06239 | LCK | Tyrosine-protein kinase Lck | 0.912 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.769 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P06239 | LCK | Tyrosine-protein kinase Lck | -0.791 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.802 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.733 |
| Tofacitinib | hsa04662 | B cell receptor signaling pathway | 3.04E-12 | 13 | P31751, P42338, P20023, P60033, P13164, P16298, Q8WV28, P07948, P11912, P21854, Q8N149, Q02750, P04049 | AKT2, PIK3CB, CR2, CD81, IFITM1, PPP3CB, BLNK, LYN, CD79A, CD72, LILRA2, MAP2K1, RAF1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 1 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.733 | P24723 | PRKCH | Protein kinase C eta type | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.79 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 1 | P07948 | LYN | Tyrosine-protein kinase Lyn | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.735 | Q15746 | MYLK | Myosin light chain kinase, smooth muscle | P20023 | CR2 | Complement receptor type 2 | 0.727 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P60033 | CD81 | CD81 antigen | 0.813 | P24723 | PRKCH | Protein kinase C eta type | P60033 | CD81 | CD81 antigen | 0.711 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P60033 | CD81 | CD81 antigen | -0.714 | P07948 | LYN | Tyrosine-protein kinase Lyn | P60033 | CD81 | CD81 antigen | -0.884 | Q2M2I8 | AAK1 | AP2-associated protein kinase 1 | P13164 | IFITM1 | Interferon-induced transmembrane protein 1 | -0.74 | Q13873 | BMPR2 | Bone morphogenetic protein receptor type-2 | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.775 | Q15746 | MYLK | Myosin light chain kinase, smooth muscle | Q8WV28 | BLNK | B-cell linker protein | 0.725 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P07948 | LYN | Tyrosine-protein kinase Lyn | -0.724 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.735 | P07948 | LYN | Tyrosine-protein kinase Lyn | P07948 | LYN | Tyrosine-protein kinase Lyn | 1 | Q15746 | MYLK | Myosin light chain kinase, smooth muscle | P11912 | CD79A | B-cell antigen receptor complex-associated protein alpha chain | 0.725 | P24723 | PRKCH | Protein kinase C eta type | P21854 | CD72 | B-cell differentiation antigen CD72 | 0.7 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P21854 | CD72 | B-cell differentiation antigen CD72 | -0.707 | P24723 | PRKCH | Protein kinase C eta type | Q8N149 | LILRA2 | Leukocyte immunoglobulin-like receptor subfamily A member 2 | -0.765 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Q8N149 | LILRA2 | Leukocyte immunoglobulin-like receptor subfamily A member 2 | 0.919 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q8N149 | LILRA2 | Leukocyte immunoglobulin-like receptor subfamily A member 2 | 0.843 | Q13873 | BMPR2 | Bone morphogenetic protein receptor type-2 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.852 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 |
| Tofacitinib | hsa04664 | Fc epsilon RI signaling pathway | 1.57E-06 | 8 | P01375, P31751, Q16539, P42338, Q9UQC2, P07948, P04049, P09917 | TNF, AKT2, MAPK14, PIK3CB, GAB2, LYN, RAF1, ALOX5 | More | | Tofacitinib | hsa04666 | Fc gamma R-mediated phagocytosis | 1.02E-03 | 7 | P08637, O75015, P42338, P04049, P23528, P06396, P14598 | FCGR3A, FCGR3B, PIK3CB, RAF1, CFL1, GSN, NCF1 | More | | Tofacitinib | hsa04668 | TNF signaling pathway | 4.51E-05 | 11 | P01375, Q12933, O00463, Q16539, Q99941, P18848, P01584, P20749, P14780, P20333, O95429 | TNF, TRAF2, TRAF5, MAPK14, CREBL1, ATF4, IL1B, BCL3, MMP9, TNFRSF1B, BAG4 | More | | Tofacitinib | hsa04672 | Intestinal immune network for IgA production | 3.76E-03 | 3 | P29965, P10747, P13765 | CD40LG, CD28, HLA-DOB | More | | Tofacitinib | hsa04710 | Circadian rhythm | 2.11E-03 | 1 | O15516 | CLOCK | More | | Tofacitinib | hsa04713 | Circadian entrainment | 1.85E-07 | 10 | P0DP23, P0DP24, Q13557, Q02153, P17252, P62873, P61952, Q14643, Q08828, P51828 | CALM1, CALM2, CAMK2D, GUCY1B3, PRKCA, GNB1, GNG11, ITPR1, ADCY1, ADCY7 | More | | Tofacitinib | hsa04714 | Thermogenesis | 4.42E-02 | 4 | Q16539, P33121, Q16718, O14521 | MAPK14, ACSL1, NDUFA5, SDHD | More | | Tofacitinib | hsa04720 | Long-term potentiation | 9.48E-11 | 12 | P17252, Q13557, P16298, P0DP23, P0DP24, Q15418, P51812, P18848, Q08828, Q02750, P04049, Q14643 | PRKCA, CAMK2D, PPP3CB, CALM1, CALM2, RPS6KA1, RPS6KA3, ATF4, ADCY1, MAP2K1, RAF1, ITPR1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P17252 | PRKCA | Protein kinase C alpha type | P17252 | PRKCA | Protein kinase C alpha type | 1 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 1 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.93 | Q05397 | PTK2 | Focal adhesion kinase 1 | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.919 | Q9HAZ1 | CLK4 | Dual specificity protein kinase CLK4 | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.861 | Q13873 | BMPR2 | Bone morphogenetic protein receptor type-2 | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.775 | P17252 | PRKCA | Protein kinase C alpha type | P0DP23 | CALM1 | Calmodulin-1 | -0.776 | O14976 | GAK | Cyclin-G-associated kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.811 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P0DP23 | CALM1 | Calmodulin-1 | 0.857 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P0DP24 | CALM2 | Calmodulin-2 | 0.786 | Q15418 | RPS6KA1 | Ribosomal protein S6 kinase alpha-1 | Q15418 | RPS6KA1 | Ribosomal protein S6 kinase alpha-1 | 1 | O14976 | GAK | Cyclin-G-associated kinase | Q15418 | RPS6KA1 | Ribosomal protein S6 kinase alpha-1 | 0.759 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | 1 | Q05397 | PTK2 | Focal adhesion kinase 1 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | 0.932 | Q9HAZ1 | CLK4 | Dual specificity protein kinase CLK4 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | 0.922 | Q13873 | BMPR2 | Bone morphogenetic protein receptor type-2 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | 0.804 | Q15418 | RPS6KA1 | Ribosomal protein S6 kinase alpha-1 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.722 | O14976 | GAK | Cyclin-G-associated kinase | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.716 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.748 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.844 | O14976 | GAK | Cyclin-G-associated kinase | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.787 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.796 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.75 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.93 | Q05397 | PTK2 | Focal adhesion kinase 1 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.898 | Q9HAZ1 | CLK4 | Dual specificity protein kinase CLK4 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.911 | Q13873 | BMPR2 | Bone morphogenetic protein receptor type-2 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.852 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P17252 | PRKCA | Protein kinase C alpha type | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.786 |
| Tofacitinib | hsa04721 | Synaptic vesicle cycle | 1.80E-02 | 2 | Q13488, P31645 | TCIRG1, SLC6A4 | More | | Tofacitinib | hsa04722 | Neurotrophin signaling pathway | 9.79E-06 | 7 | Q05655, P31751, P04049, P52566, P51617, P10415, P0DP23 | PRKCD, AKT2, RAF1, ARHGDIB, IRAK1, BCL2, CALM1 | More | | Tofacitinib | hsa04723 | Retrograde endocannabinoid signaling | 1.69E-03 | 7 | Q14643, P17252, P62873, P61952, Q08828, O15239, Q16718 | ITPR1, PRKCA, GNB1, GNG11, ADCY1, NDUFA1, NDUFA5 | More | | Tofacitinib | hsa04724 | Glutamatergic synapse | 2.84E-05 | 7 | O15399, Q08828, P62873, P63218, P50151, P61952, P15104 | GRIN2D, ADCY1, GNB1, GNG5, GNG10, GNG11, GLUL | More | | Tofacitinib | hsa04725 | Cholinergic synapse | 3.25E-08 | 14 | Q08828, P51828, P22694, Q14643, P17252, P62873, P63218, P50151, P61952, P18848, Q13557, P42338, P31751, P10415 | ADCY1, ADCY7, PRKACB, ITPR1, PRKCA, GNB1, GNG5, GNG10, GNG11, ATF4, CAMK2D, PIK3CB, AKT2, BCL2 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O14976 | GAK | Cyclin-G-associated kinase | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.787 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.796 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.75 | O14976 | GAK | Cyclin-G-associated kinase | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.753 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.726 | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | 0.71 | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.768 | P17252 | PRKCA | Protein kinase C alpha type | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.786 | P17252 | PRKCA | Protein kinase C alpha type | P17252 | PRKCA | Protein kinase C alpha type | 1 | P17252 | PRKCA | Protein kinase C alpha type | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.852 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.789 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.747 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.752 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P61952 | GNG11 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 | -0.756 | O14976 | GAK | Cyclin-G-associated kinase | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.716 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.748 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.844 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 1 | O14976 | GAK | Cyclin-G-associated kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.703 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.726 | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.723 | P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 |
| Tofacitinib | hsa04726 | Serotonergic synapse | 1.33E-02 | 1 | P04049 | RAF1 | More | | Tofacitinib | hsa04727 | GABAergic synapse | 6.02E-08 | 9 | Q08828, P51828, P62873, P63218, P50151, P61952, P15104, P46459, Q15111 | ADCY1, ADCY7, GNB1, GNG5, GNG10, GNG11, GLUL, NSF, PLCL1 | More | | Tofacitinib | hsa04728 | Dopaminergic synapse | 1.32E-09 | 18 | Q14643, P17252, P62873, P50151, P61952, P31751, P49841, Q99941, P18848, Q16539, Q13557, P49407, Q13362, Q14738, P0DP23, P0DP24, O15516, P48058 | ITPR1, PRKCA, GNB1, GNG10, GNG11, AKT2, GSK3B, CREBL1, ATF4, MAPK14, CAMK2D, ARRB1, PPP2R5C, PPP2R5D, CALM1, CALM2, CLOCK, GRIA4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P17252 | PRKCA | Protein kinase C alpha type | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.786 | P17252 | PRKCA | Protein kinase C alpha type | P17252 | PRKCA | Protein kinase C alpha type | 1 | P17252 | PRKCA | Protein kinase C alpha type | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.852 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.789 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.766 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P61952 | GNG11 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 | -0.756 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.726 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 1 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.733 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.774 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.72 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.801 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.773 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.748 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.844 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.802 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.7 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.741 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 1 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P49407 | ARRB1 | Beta-arrestin-1 | -0.738 | P17252 | PRKCA | Protein kinase C alpha type | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | 0.745 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | 0.804 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | 0.735 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q14738 | PPP2R5D | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform | 0.781 | P17252 | PRKCA | Protein kinase C alpha type | P0DP23 | CALM1 | Calmodulin-1 | -0.776 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | P0DP24 | CALM2 | Calmodulin-2 | 0.763 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P0DP23 | CALM1 | Calmodulin-1 | 0.857 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P0DP24 | CALM2 | Calmodulin-2 | 0.786 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.761 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | O15516 | CLOCK | Circadian locomoter output cycles protein kaput | 0.703 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | O15516 | CLOCK | Circadian locomoter output cycles protein kaput | 0.72 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P48058 | GRIA4 | Glutamate receptor 4 | 0.748 |
| Tofacitinib | hsa04730 | Long-term depression | 1.25E-04 | 2 | P08069, P04049 | IGF1R, RAF1 | More | | Tofacitinib | hsa04740 | Olfactory transduction | 5.99E-06 | 5 | P62873, Q9H255, Q13557, P0DP23, P0DP24 | GNB1, OR51E2, CAMK2D, CALM1, CALM2 | More | | Tofacitinib | hsa04742 | Taste transduction | 2.43E-05 | 2 | P30939, P17612 | HTR1F, PRKACA | More | | Tofacitinib | hsa04744 | Phototransduction | 1.02E-08 | 3 | P62873, P0DP23, P0DP24 | GNB1, CALM1, CALM2 | More | | Tofacitinib | hsa04750 | Inflammatory mediator regulation of TRP channels | 8.03E-09 | 11 | P14778, P01584, Q08828, P51828, Q13557, P19174, P42338, P24723, Q04759, P0DP23, P0DP24 | IL1R1, IL1B, ADCY1, ADCY7, CAMK2D, PLCG1, PIK3CB, PRKCH, PRKCQ, CALM1, CALM2 | More | | Tofacitinib | hsa04810 | Regulation of actin cytoskeleton | 1.78E-02 | 6 | Q13009, P04049, P11215, P16144, P60709, P01042 | TIAM1, RAF1, ITGAM, ITGB4, ACTB, KNG1 | More | | Tofacitinib | hsa04910 | Insulin signaling pathway | 2.40E-05 | 3 | P0DP23, P04049, P31751 | CALM1, RAF1, AKT2 | More | | Tofacitinib | hsa04911 | Insulin secretion | 1.04E-06 | 5 | Q08828, P51828, Q99941, P18848, Q13557 | ADCY1, ADCY7, CREBL1, ATF4, CAMK2D | More | | Tofacitinib | hsa04912 | GnRH signaling pathway | 1.15E-06 | 9 | P17252, Q08828, P51828, P18848, Q9Y6R4, Q14643, P0DP23, P04049, P45985 | PRKCA, ADCY1, ADCY7, ATF4, MAP3K4, ITPR1, CALM1, RAF1, MAP2K4 | More | | Tofacitinib | hsa04913 | Ovarian steroidogenesis | 6.44E-04 | 4 | P42330, P22694, P06213, P08069 | AKR1C3, PRKACB, INSR, IGF1R | More | | Tofacitinib | hsa04914 | Progesterone-mediated oocyte maturation | 2.17E-09 | 9 | P08069, Q17RY0, P42338, Q13370, Q9Y6D9, P08238, P51812, Q02750, P04049 | IGF1R, CPEB4, PIK3CB, PDE3B, MAD1L1, HSP90AB1, RPS6KA3, MAP2K1, RAF1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P08069 | IGF1R | Insulin-like growth factor 1 receptor | P08069 | IGF1R | Insulin-like growth factor 1 receptor | 1 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | Q17RY0 | CPEB4 | Cytoplasmic polyadenylation element-binding protein 4 | 0.938 | Q05397 | PTK2 | Focal adhesion kinase 1 | Q17RY0 | CPEB4 | Cytoplasmic polyadenylation element-binding protein 4 | 0.909 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | Q17RY0 | CPEB4 | Cytoplasmic polyadenylation element-binding protein 4 | 0.859 | Q9HAZ1 | CLK4 | Dual specificity protein kinase CLK4 | Q17RY0 | CPEB4 | Cytoplasmic polyadenylation element-binding protein 4 | 0.92 | Q13873 | BMPR2 | Bone morphogenetic protein receptor type-2 | Q17RY0 | CPEB4 | Cytoplasmic polyadenylation element-binding protein 4 | 0.715 | P29375 | JARID1A | Lysine-specific demethylase 5A | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.79 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | -0.737 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | Q9Y6D9 | MAD1L1 | Mitotic spindle assembly checkpoint protein MAD1 | -0.815 | Q05397 | PTK2 | Focal adhesion kinase 1 | Q9Y6D9 | MAD1L1 | Mitotic spindle assembly checkpoint protein MAD1 | -0.754 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | Q9Y6D9 | MAD1L1 | Mitotic spindle assembly checkpoint protein MAD1 | -0.764 | Q9HAZ1 | CLK4 | Dual specificity protein kinase CLK4 | Q9Y6D9 | MAD1L1 | Mitotic spindle assembly checkpoint protein MAD1 | -0.822 | P29375 | JARID1A | Lysine-specific demethylase 5A | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.711 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | 1 | Q05397 | PTK2 | Focal adhesion kinase 1 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | 0.932 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | 0.93 | Q9HAZ1 | CLK4 | Dual specificity protein kinase CLK4 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | 0.922 | Q13873 | BMPR2 | Bone morphogenetic protein receptor type-2 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | 0.804 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.93 | Q05397 | PTK2 | Focal adhesion kinase 1 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.898 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 1 | Q9HAZ1 | CLK4 | Dual specificity protein kinase CLK4 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.911 | Q13873 | BMPR2 | Bone morphogenetic protein receptor type-2 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.852 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 |
| Tofacitinib | hsa04915 | Estrogen signaling pathway | 8.54E-10 | 12 | P04049, Q99941, P18848, Q08828, P51828, P31751, P07900, P0DMV8, P11142, P0DP23, P0DP24, Q15788 | RAF1, CREBL1, ATF4, ADCY1, ADCY7, AKT2, HSP90AA1, HSPA1A, HSPA8, CALM1, CALM2, NCOA1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.801 | O14976 | GAK | Cyclin-G-associated kinase | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.716 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.748 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.844 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.84 | O14976 | GAK | Cyclin-G-associated kinase | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.787 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.796 | Q96RR4 | CAMKK2 | Calcium/calmodulin-dependent protein kinase kinase 2 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.824 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.75 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.834 | O14976 | GAK | Cyclin-G-associated kinase | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.753 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.726 | O14976 | GAK | Cyclin-G-associated kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.703 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.726 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 1 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 0.763 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P0DMV8 | HSPA1A | Heat shock 70 kDa protein 1A | 0.753 | O14976 | GAK | Cyclin-G-associated kinase | P0DMV8 | HSPA1A | Heat shock 70 kDa protein 1A | 0.702 | Q96RR4 | CAMKK2 | Calcium/calmodulin-dependent protein kinase kinase 2 | P0DMV8 | HSPA1A | Heat shock 70 kDa protein 1A | 0.81 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P0DMV8 | HSPA1A | Heat shock 70 kDa protein 1A | 0.753 | O14976 | GAK | Cyclin-G-associated kinase | P0DMV8 | HSPA1A | Heat shock 70 kDa protein 1A | 0.702 | Q96RR4 | CAMKK2 | Calcium/calmodulin-dependent protein kinase kinase 2 | P0DMV8 | HSPA1A | Heat shock 70 kDa protein 1A | 0.81 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.745 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P0DP23 | CALM1 | Calmodulin-1 | 0.822 | O14976 | GAK | Cyclin-G-associated kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.811 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P0DP23 | CALM1 | Calmodulin-1 | 0.857 | Q96RR4 | CAMKK2 | Calcium/calmodulin-dependent protein kinase kinase 2 | P0DP23 | CALM1 | Calmodulin-1 | 0.7 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P0DP24 | CALM2 | Calmodulin-2 | 0.786 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.761 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q15788 | NCOA1 | Nuclear receptor coactivator 1 | 0.86 | O14976 | GAK | Cyclin-G-associated kinase | Q15788 | NCOA1 | Nuclear receptor coactivator 1 | 0.711 | Q96RR4 | CAMKK2 | Calcium/calmodulin-dependent protein kinase kinase 2 | Q15788 | NCOA1 | Nuclear receptor coactivator 1 | 0.723 |
| Tofacitinib | hsa04916 | Melanogenesis | 7.31E-04 | 4 | P0DP23, Q08828, P51828, P04049 | CALM1, ADCY1, ADCY7, RAF1 | More | | Tofacitinib | hsa04917 | Prolactin signaling pathway | 3.49E-04 | 2 | P31751, P04049 | AKT2, RAF1 | More | | Tofacitinib | hsa04918 | Thyroid hormone synthesis | 2.47E-04 | 5 | Q08828, Q99941, P18848, P02768, P05543 | ADCY1, CREBL1, ATF4, ALB, SERPINA7 | More | | Tofacitinib | hsa04919 | Thyroid hormone signaling pathway | 1.21E-04 | 7 | P19174, P04049, P42224, P60709, Q13547, Q9UM47, P01106 | PLCG1, RAF1, STAT1, ACTB, HDAC1, NOTCH3, MYC | More | | Tofacitinib | hsa04920 | Adipocytokine signaling pathway | 4.19E-02 | 1 | P31751 | AKT2 | More | | Tofacitinib | hsa04921 | Oxytocin signaling pathway | 2.32E-02 | 1 | P04049 | RAF1 | More | | Tofacitinib | hsa04922 | Glucagon signaling pathway | 3.10E-04 | 7 | P14618, P06737, Q12778, P31751, Q13370, P0DP23, Q14643 | PKM2, PYGL, FOXO1, AKT2, PDE3B, CALM1, ITPR1 | More | | Tofacitinib | hsa04923 | Regulation of lipolysis in adipocytes | 5.39E-06 | 4 | Q08828, P51828, P06213, P31751 | ADCY1, ADCY7, INSR, AKT2 | More | | Tofacitinib | hsa04924 | Renin secretion | 8.84E-10 | 5 | P22694, P07550, Q14643, Q13370, P0DP23 | PRKACB, ADRB2, ITPR1, PDE3B, CALM1 | More | | Tofacitinib | hsa04925 | Aldosterone synthesis and secretion | 1.79E-08 | 8 | Q99941, P18848, Q08828, P51828, P0DP24, P0DP23, Q13557, P23634 | CREBL1, ATF4, ADCY1, ADCY7, CALM2, CALM1, CAMK2D, ATP2B4 | More | | Tofacitinib | hsa04926 | Relaxin signaling pathway | 1.62E-07 | 14 | P31751, P42338, P62873, P63218, P50151, P61952, Q99941, P18848, P49767, Q08828, P51828, P04049, P30679, P49407 | AKT2, PIK3CB, GNB1, GNG5, GNG10, GNG11, CREBL1, ATF4, VEGFC, ADCY1, ADCY7, RAF1, GNA15, ARRB1 | More | | Tofacitinib | hsa04927 | Cortisol synthesis and secretion | 1.37E-06 | 6 | Q14643, Q99941, P18848, Q08828, P51828, P22694 | ITPR1, CREBL1, ATF4, ADCY1, ADCY7, PRKACB | More | | Tofacitinib | hsa04928 | Parathyroid hormone synthesis, secretion and action | 2.75E-03 | 5 | Q14643, P22694, P23771, P04049, P10415 | ITPR1, PRKACB, GATA3, RAF1, BCL2 | More | | Tofacitinib | hsa04929 | GnRH secretion | 6.93E-06 | 4 | P42338, P31751, P49407, P04049 | PIK3CB, AKT2, ARRB1, RAF1 | More | | Tofacitinib | hsa04930 | Type II diabetes mellitus | 6.29E-05 | 3 | P06213, Q05655, Q02156 | INSR, PRKCD, PRKCE | More | | Tofacitinib | hsa04932 | Non-alcoholic fatty liver disease | 4.37E-12 | 12 | P31751, Q14790, O43521, P18848, P48023, O75460, P01584, P13073, P12074, O15239, O95298, P19404 | AKT2, CASP8, BCL2L11, ATF4, FASLG, ERN1, IL1B, COX4I1, COX6A1, NDUFA1, NDUFC2, NDUFV2 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O14976 | GAK | Cyclin-G-associated kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.703 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.726 | Q96BR1 | SGK3 | Serine/threonine-protein kinase Sgk3 | Q14790 | CASP8 | Caspase-8 | -0.824 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | O43521 | BCL2L11 | Bcl-2-like protein 11 | 0.708 | O14976 | GAK | Cyclin-G-associated kinase | O43521 | BCL2L11 | Bcl-2-like protein 11 | 0.745 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | O43521 | BCL2L11 | Bcl-2-like protein 11 | 0.734 | O14976 | GAK | Cyclin-G-associated kinase | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.716 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.748 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.844 | Q96BR1 | SGK3 | Serine/threonine-protein kinase Sgk3 | P48023 | FASLG | Tumor necrosis factor ligand superfamily member 6 | -0.787 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.79 | O14976 | GAK | Cyclin-G-associated kinase | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.781 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 1 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.72 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.734 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P01584 | IL1B | Interleukin-1 beta | 0.799 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | P01584 | IL1B | Interleukin-1 beta | 0.786 | O14976 | GAK | Cyclin-G-associated kinase | P01584 | IL1B | Interleukin-1 beta | 0.742 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | P01584 | IL1B | Interleukin-1 beta | 0.826 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | P01584 | IL1B | Interleukin-1 beta | 0.733 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P01584 | IL1B | Interleukin-1 beta | 0.735 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P01584 | IL1B | Interleukin-1 beta | 0.725 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.722 | O14976 | GAK | Cyclin-G-associated kinase | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.759 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.712 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.761 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.742 | O14976 | GAK | Cyclin-G-associated kinase | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.723 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.737 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.722 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.763 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.766 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.885 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | O95298 | NDUFC2 | NADH dehydrogenase [ubiquinone] 1 subunit C2 | 0.83 | O14976 | GAK | Cyclin-G-associated kinase | O95298 | NDUFC2 | NADH dehydrogenase [ubiquinone] 1 subunit C2 | 0.73 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | O95298 | NDUFC2 | NADH dehydrogenase [ubiquinone] 1 subunit C2 | 0.722 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | O95298 | NDUFC2 | NADH dehydrogenase [ubiquinone] 1 subunit C2 | 0.778 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | P19404 | NDUFV2 | NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial | 0.747 |
| Tofacitinib | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.27E-02 | 5 | P42224, P10415, Q12778, P49767, P17252 | STAT1, BCL2, FOXO1, VEGFC, PRKCA | More | | Tofacitinib | hsa04934 | Cushing syndrome | 7.95E-08 | 9 | Q14643, Q99941, P18848, Q08828, P51828, P22694, O15169, Q13557, P04628 | ITPR1, CREBL1, ATF4, ADCY1, ADCY7, PRKACB, AXIN1, CAMK2D, WNT1 | More | | Tofacitinib | hsa04935 | Growth hormone synthesis, secretion and action | 5.87E-04 | 6 | Q08828, P51828, P04049, P18848, P31751, P45985 | ADCY1, ADCY7, RAF1, ATF4, AKT2, MAP2K4 | More | | Tofacitinib | hsa04940 | Type I diabetes mellitus | 1.55E-02 | 3 | P10747, P13765, P01375 | CD28, HLA-DOB, TNF | More | | Tofacitinib | hsa04960 | Aldosterone-regulated sodium reabsorption | 7.59E-03 | 2 | O00141, P06213 | SGK, INSR | More | | Tofacitinib | hsa04964 | Proximal tubule bicarbonate reclamation | 4.48E-02 | 1 | P00918 | CA2 | More | | Tofacitinib | hsa04966 | Collecting duct acid secretion | 1.95E-03 | 3 | Q13488, P00918, Q9Y666 | TCIRG1, CA2, SLC12A7 | More | | Tofacitinib | hsa04970 | Salivary secretion | 1.41E-10 | 10 | P07550, Q08828, P51828, P22694, Q14643, P23634, P0DP23, P0DP24, Q02153, P49913 | ADRB2, ADCY1, ADCY7, PRKACB, ITPR1, ATP2B4, CALM1, CALM2, GUCY1B3, CAMP | More | | Tofacitinib | hsa04971 | Gastric acid secretion | 3.36E-07 | 6 | Q08828, P51828, P15311, P0DP24, P0DP23, Q13557 | ADCY1, ADCY7, VIL2, CALM2, CALM1, CAMK2D | More | | Tofacitinib | hsa04973 | Carbohydrate digestion and absorption | 2.41E-02 | 1 | P31751 | AKT2 | More | | Tofacitinib | hsa04974 | Protein digestion and absorption | 1.22E-03 | 2 | Q7Z2H8, P02452 | SLC36A1, COL1A1 | More | | Tofacitinib | hsa04975 | Fat digestion and absorption | 4.83E-02 | 1 | O14494 | PLPP1 | More | | Tofacitinib | hsa04976 | Bile secretion | 1.97E-04 | 3 | Q08828, P51828, Q14032 | ADCY1, ADCY7, BAAT | More | | Tofacitinib | hsa04979 | Cholesterol metabolism | 1.37E-02 | 3 | P38571, P61916, P45880 | LIPA, NPC2, VDAC2 | More | | Tofacitinib | hsa05010 | Alzheimer disease | 1.66E-09 | 26 | P49768, Q92542, O15239, Q16718, O95298, P19404, O14521, P05496, P13073, P12074, Q14643, Q00535, O75460, P0DP23, P01584, Q12933, P18848, Q13509, P68371, O15169, P67870, P31751, P05141, Q08752, P28070, P43686 | PSEN1, NCSTN, NDUFA1, NDUFA5, NDUFC2, NDUFV2, SDHD, ATP5G1, COX4I1, COX6A1, ITPR1, CDK5, ERN1, CALM1, IL1B, TRAF2, ATF4, TUBB3, TUBB2C, AXIN1, CSNK2B, AKT2, SLC25A5, PPID, PSMB4, PSMC4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P49768 | PSEN1 | Presenilin-1 | -0.732 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q92542 | NCSTN | Nicastrin | -0.729 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | -0.834 | P17252 | PRKCA | Protein kinase C alpha type | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.811 | O14976 | GAK | Cyclin-G-associated kinase | O95298 | NDUFC2 | NADH dehydrogenase [ubiquinone] 1 subunit C2 | 0.73 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | O95298 | NDUFC2 | NADH dehydrogenase [ubiquinone] 1 subunit C2 | 0.778 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | P19404 | NDUFV2 | NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial | 0.747 | P17252 | PRKCA | Protein kinase C alpha type | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.822 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P05496 | ATP5G1 | ATP synthase F(0) complex subunit C1, mitochondrial | -0.815 | Q15418 | RPS6KA1 | Ribosomal protein S6 kinase alpha-1 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.758 | O14976 | GAK | Cyclin-G-associated kinase | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.759 | O14976 | GAK | Cyclin-G-associated kinase | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.723 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | -0.715 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.722 | P17252 | PRKCA | Protein kinase C alpha type | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.786 | O14976 | GAK | Cyclin-G-associated kinase | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | 0.835 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | 1 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | 0.726 | O14976 | GAK | Cyclin-G-associated kinase | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.781 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.72 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.734 | P17252 | PRKCA | Protein kinase C alpha type | P0DP23 | CALM1 | Calmodulin-1 | -0.776 | O14976 | GAK | Cyclin-G-associated kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.811 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P0DP23 | CALM1 | Calmodulin-1 | 0.857 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.761 | O14976 | GAK | Cyclin-G-associated kinase | P01584 | IL1B | Interleukin-1 beta | 0.742 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | P01584 | IL1B | Interleukin-1 beta | 0.733 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P01584 | IL1B | Interleukin-1 beta | 0.735 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q12933 | TRAF2 | TNF receptor-associated factor 2 | -0.771 | Q15418 | RPS6KA1 | Ribosomal protein S6 kinase alpha-1 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.722 | O14976 | GAK | Cyclin-G-associated kinase | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.716 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.748 | P17252 | PRKCA | Protein kinase C alpha type | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.756 | P17252 | PRKCA | Protein kinase C alpha type | P68371 | TUBB2C | Tubulin beta-4B chain | -0.842 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | O15169 | AXIN1 | Axin-1 | -0.74 | Q15418 | RPS6KA1 | Ribosomal protein S6 kinase alpha-1 | P67870 | CSNK2B | Casein kinase II subunit beta | 0.768 | O14976 | GAK | Cyclin-G-associated kinase | P67870 | CSNK2B | Casein kinase II subunit beta | 0.748 | O14976 | GAK | Cyclin-G-associated kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.703 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.726 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 1 | Q15418 | RPS6KA1 | Ribosomal protein S6 kinase alpha-1 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.715 | O14976 | GAK | Cyclin-G-associated kinase | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.716 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.779 | P17252 | PRKCA | Protein kinase C alpha type | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | 0.725 | O14976 | GAK | Cyclin-G-associated kinase | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.773 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.758 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.736 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P43686 | PSMC4 | 26S proteasome regulatory subunit 6B | -0.729 |
| Tofacitinib | hsa05012 | Parkinson disease | 4.93E-05 | 19 | O15239, Q16718, O95298, O14521, P13073, P12074, P05496, P05141, P12236, O75460, P18848, P28070, P43686, Q14643, P0DP23, P0DP24, Q13557, Q13509, P68371 | NDUFA1, NDUFA5, NDUFC2, SDHD, COX4I1, COX6A1, ATP5G1, SLC25A5, SLC25A6, ERN1, ATF4, PSMB4, PSMC4, ITPR1, CALM1, CALM2, CAMK2D, TUBB3, TUBB2C | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.885 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.731 | P17252 | PRKCA | Protein kinase C alpha type | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.811 | O14976 | GAK | Cyclin-G-associated kinase | O95298 | NDUFC2 | NADH dehydrogenase [ubiquinone] 1 subunit C2 | 0.73 | P17252 | PRKCA | Protein kinase C alpha type | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.822 | O14976 | GAK | Cyclin-G-associated kinase | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.759 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.712 | O14976 | GAK | Cyclin-G-associated kinase | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.723 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.763 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P05496 | ATP5G1 | ATP synthase F(0) complex subunit C1, mitochondrial | 0.818 | O14976 | GAK | Cyclin-G-associated kinase | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.716 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.779 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.723 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P12236 | SLC25A6 | ADP/ATP translocase 3 | 0.793 | O14976 | GAK | Cyclin-G-associated kinase | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.781 | O14976 | GAK | Cyclin-G-associated kinase | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.716 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.844 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.75 | O14976 | GAK | Cyclin-G-associated kinase | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.773 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P43686 | PSMC4 | 26S proteasome regulatory subunit 6B | 0.78 | P17252 | PRKCA | Protein kinase C alpha type | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.786 | P17252 | PRKCA | Protein kinase C alpha type | P0DP23 | CALM1 | Calmodulin-1 | -0.776 | O14976 | GAK | Cyclin-G-associated kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.811 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P0DP24 | CALM2 | Calmodulin-2 | 0.786 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 1 | P17252 | PRKCA | Protein kinase C alpha type | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.756 | P17252 | PRKCA | Protein kinase C alpha type | P68371 | TUBB2C | Tubulin beta-4B chain | -0.842 |
| Tofacitinib | hsa05014 | Amyotrophic lateral sclerosis | 6.58E-03 | 15 | P01375, Q16718, P19404, O14521, P12074, P36542, O75460, P28070, Q8TEV9, P09651, Q7Z3B4, P35658, P43243, Q09161, Q16629 | TNF, NDUFA5, NDUFV2, SDHD, COX6A1, ATP5C1, ERN1, PSMB4, SMCR8, HNRNPA1, NUP54, NUP214, MATR3, NCBP1, SFRS7 | More | | Tofacitinib | hsa05016 | Huntington disease | 1.51E-06 | 12 | O95298, P19404, P13073, P12074, P24928, P30876, P62487, P05141, P45880, O75460, P28070, O00232 | NDUFC2, NDUFV2, COX4I1, COX6A1, POLR2A, POLR2B, POLR2G, SLC25A5, VDAC2, ERN1, PSMB4, PSMD12 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P23458 | JAK1 | Tyrosine-protein kinase JAK1 | O95298 | NDUFC2 | NADH dehydrogenase [ubiquinone] 1 subunit C2 | 0.83 | O14976 | GAK | Cyclin-G-associated kinase | O95298 | NDUFC2 | NADH dehydrogenase [ubiquinone] 1 subunit C2 | 0.73 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | O95298 | NDUFC2 | NADH dehydrogenase [ubiquinone] 1 subunit C2 | 0.778 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | P19404 | NDUFV2 | NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial | 0.747 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.722 | O14976 | GAK | Cyclin-G-associated kinase | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.759 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.761 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.802 | O14976 | GAK | Cyclin-G-associated kinase | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.723 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.722 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P24928 | POLR2A | DNA-directed RNA polymerase II subunit RPB1 | 0.784 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | P24928 | POLR2A | DNA-directed RNA polymerase II subunit RPB1 | 0.763 | O14976 | GAK | Cyclin-G-associated kinase | P24928 | POLR2A | DNA-directed RNA polymerase II subunit RPB1 | 0.718 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P24928 | POLR2A | DNA-directed RNA polymerase II subunit RPB1 | 0.709 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P30876 | POLR2B | DNA-directed RNA polymerase II subunit RPB2 | 0.795 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | P30876 | POLR2B | DNA-directed RNA polymerase II subunit RPB2 | 0.708 | O14976 | GAK | Cyclin-G-associated kinase | P30876 | POLR2B | DNA-directed RNA polymerase II subunit RPB2 | 0.713 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P30876 | POLR2B | DNA-directed RNA polymerase II subunit RPB2 | 0.703 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P62487 | POLR2G | DNA-directed RNA polymerase II subunit RPB7 | 0.855 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | P62487 | POLR2G | DNA-directed RNA polymerase II subunit RPB7 | 0.813 | O14976 | GAK | Cyclin-G-associated kinase | P62487 | POLR2G | DNA-directed RNA polymerase II subunit RPB7 | 0.776 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | P62487 | POLR2G | DNA-directed RNA polymerase II subunit RPB7 | 0.795 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P62487 | POLR2G | DNA-directed RNA polymerase II subunit RPB7 | 0.758 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.716 | O14976 | GAK | Cyclin-G-associated kinase | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.716 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.779 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | P45880 | VDAC2 | Voltage-dependent anion-selective channel protein 2 | 0.748 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.79 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.856 | O14976 | GAK | Cyclin-G-associated kinase | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.781 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.72 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.734 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.85 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.791 | O14976 | GAK | Cyclin-G-associated kinase | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.773 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.758 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.736 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | O00232 | PSMD12 | 26S proteasome non-ATPase regulatory subunit 12 | -0.703 |
| Tofacitinib | hsa05017 | Spinocerebellar ataxia | 1.88E-04 | 9 | Q92915, O75460, Q8TB72, O15399, P42338, P31751, P28070, P05141, P21796 | FGF14, ERN1, PUM2, GRIN2D, PIK3CB, AKT2, PSMB4, SLC25A5, VDAC1 | More | | Tofacitinib | hsa05020 | Prion disease | 1.01E-06 | 23 | P01584, P46531, P0DMV8, P11142, O15239, Q16718, O95298, O14521, P05496, P13073, P12074, Q14643, P18848, P05141, P12236, P28070, P43686, Q13509, P68371, P67870, Q99941, P14598, Q15080 | IL1B, NOTCH1, HSPA1A, HSPA8, NDUFA1, NDUFA5, NDUFC2, SDHD, ATP5G1, COX4I1, COX6A1, ITPR1, ATF4, SLC25A5, SLC25A6, PSMB4, PSMC4, TUBB3, TUBB2C, CSNK2B, CREBL1, NCF1, NCF4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O14976 | GAK | Cyclin-G-associated kinase | P01584 | IL1B | Interleukin-1 beta | 0.742 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P01584 | IL1B | Interleukin-1 beta | 0.725 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P46531 | NOTCH1 | Neurogenic locus notch homolog protein 1 | 0.784 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P46531 | NOTCH1 | Neurogenic locus notch homolog protein 1 | 0.735 | O14976 | GAK | Cyclin-G-associated kinase | P0DMV8 | HSPA1A | Heat shock 70 kDa protein 1A | 0.702 | O14976 | GAK | Cyclin-G-associated kinase | P0DMV8 | HSPA1A | Heat shock 70 kDa protein 1A | 0.702 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.745 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.885 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.731 | P17252 | PRKCA | Protein kinase C alpha type | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.811 | O14976 | GAK | Cyclin-G-associated kinase | O95298 | NDUFC2 | NADH dehydrogenase [ubiquinone] 1 subunit C2 | 0.73 | P17252 | PRKCA | Protein kinase C alpha type | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.822 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P05496 | ATP5G1 | ATP synthase F(0) complex subunit C1, mitochondrial | 0.818 | Q15418 | RPS6KA1 | Ribosomal protein S6 kinase alpha-1 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.758 | O14976 | GAK | Cyclin-G-associated kinase | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.759 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.712 | O14976 | GAK | Cyclin-G-associated kinase | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.723 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.763 | P17252 | PRKCA | Protein kinase C alpha type | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.786 | Q15418 | RPS6KA1 | Ribosomal protein S6 kinase alpha-1 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.722 | O14976 | GAK | Cyclin-G-associated kinase | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.716 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.844 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.75 | Q15418 | RPS6KA1 | Ribosomal protein S6 kinase alpha-1 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.715 | O14976 | GAK | Cyclin-G-associated kinase | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.716 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.779 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.723 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P12236 | SLC25A6 | ADP/ATP translocase 3 | 0.793 | O14976 | GAK | Cyclin-G-associated kinase | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.773 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P43686 | PSMC4 | 26S proteasome regulatory subunit 6B | 0.78 | P17252 | PRKCA | Protein kinase C alpha type | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.756 | P17252 | PRKCA | Protein kinase C alpha type | P68371 | TUBB2C | Tubulin beta-4B chain | -0.842 | Q15418 | RPS6KA1 | Ribosomal protein S6 kinase alpha-1 | P67870 | CSNK2B | Casein kinase II subunit beta | 0.768 | O14976 | GAK | Cyclin-G-associated kinase | P67870 | CSNK2B | Casein kinase II subunit beta | 0.748 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.801 | P17252 | PRKCA | Protein kinase C alpha type | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.821 | P17252 | PRKCA | Protein kinase C alpha type | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.836 |
| Tofacitinib | hsa05022 | Pathways of neurodegeneration - multiple diseases | 7.23E-10 | 35 | Q14643, Q13509, P68371, P67870, P10415, O15239, Q16718, O95298, P19404, O14521, P13073, P12074, P05496, Q06055, Q8TEV9, O75460, P18848, Q12933, Q13561, P05141, P45880, P17252, Q15078, Q00535, O15169, P01584, P49768, Q08752, O15020, P0DP23, P0DP24, Q13557, P62987, P28070, P43686 | ITPR1, TUBB3, TUBB2C, CSNK2B, BCL2, NDUFA1, NDUFA5, NDUFC2, NDUFV2, SDHD, COX4I1, COX6A1, ATP5G1, ATP5G2, SMCR8, ERN1, ATF4, TRAF2, DCTN2, SLC25A5, VDAC2, PRKCA, CDK5R1, CDK5, AXIN1, IL1B, PSEN1, PPID, SPTBN2, CALM1, CALM2, CAMK2D, UBA52, PSMB4, PSMC4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P17252 | PRKCA | Protein kinase C alpha type | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.786 | P17252 | PRKCA | Protein kinase C alpha type | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.756 | P17252 | PRKCA | Protein kinase C alpha type | P68371 | TUBB2C | Tubulin beta-4B chain | -0.842 | O14976 | GAK | Cyclin-G-associated kinase | P67870 | CSNK2B | Casein kinase II subunit beta | 0.748 | P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | -0.834 | P17252 | PRKCA | Protein kinase C alpha type | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.811 | O14976 | GAK | Cyclin-G-associated kinase | O95298 | NDUFC2 | NADH dehydrogenase [ubiquinone] 1 subunit C2 | 0.73 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | O95298 | NDUFC2 | NADH dehydrogenase [ubiquinone] 1 subunit C2 | 0.778 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | P19404 | NDUFV2 | NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial | 0.747 | P17252 | PRKCA | Protein kinase C alpha type | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.822 | O14976 | GAK | Cyclin-G-associated kinase | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.759 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.802 | O14976 | GAK | Cyclin-G-associated kinase | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.723 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | -0.715 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.722 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P05496 | ATP5G1 | ATP synthase F(0) complex subunit C1, mitochondrial | -0.815 | P30530 | AXL | Tyrosine-protein kinase receptor UFO | Q06055 | ATP5G2 | ATP synthase F(0) complex subunit C2, mitochondrial | -0.735 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | Q8TEV9 | SMCR8 | Guanine nucleotide exchange protein SMCR8 | 0.756 | O14976 | GAK | Cyclin-G-associated kinase | Q8TEV9 | SMCR8 | Guanine nucleotide exchange protein SMCR8 | 0.866 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | Q8TEV9 | SMCR8 | Guanine nucleotide exchange protein SMCR8 | 0.716 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q8TEV9 | SMCR8 | Guanine nucleotide exchange protein SMCR8 | 0.807 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.856 | O14976 | GAK | Cyclin-G-associated kinase | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.781 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.72 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.734 | O14976 | GAK | Cyclin-G-associated kinase | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.716 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.748 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q12933 | TRAF2 | TNF receptor-associated factor 2 | -0.771 | P17252 | PRKCA | Protein kinase C alpha type | Q13561 | DCTN2 | Dynactin subunit 2 | -0.844 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.716 | O14976 | GAK | Cyclin-G-associated kinase | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.716 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.779 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | P45880 | VDAC2 | Voltage-dependent anion-selective channel protein 2 | 0.748 | P17252 | PRKCA | Protein kinase C alpha type | P17252 | PRKCA | Protein kinase C alpha type | 1 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | Q15078 | CDK5R1 | Cyclin-dependent kinase 5 activator 1 | -0.719 | O14976 | GAK | Cyclin-G-associated kinase | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | 0.835 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | 1 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | 0.726 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | O15169 | AXIN1 | Axin-1 | -0.74 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | P01584 | IL1B | Interleukin-1 beta | 0.834 | O14976 | GAK | Cyclin-G-associated kinase | P01584 | IL1B | Interleukin-1 beta | 0.742 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | P01584 | IL1B | Interleukin-1 beta | 0.733 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P01584 | IL1B | Interleukin-1 beta | 0.735 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P49768 | PSEN1 | Presenilin-1 | -0.732 | P17252 | PRKCA | Protein kinase C alpha type | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | 0.725 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | O15020 | SPTBN2 | Spectrin beta chain, non-erythrocytic 2 | -0.718 | P30530 | AXL | Tyrosine-protein kinase receptor UFO | O15020 | SPTBN2 | Spectrin beta chain, non-erythrocytic 2 | 0.738 | P17252 | PRKCA | Protein kinase C alpha type | P0DP23 | CALM1 | Calmodulin-1 | -0.776 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | P0DP24 | CALM2 | Calmodulin-2 | 0.763 | O14976 | GAK | Cyclin-G-associated kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.811 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P0DP23 | CALM1 | Calmodulin-1 | 0.857 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.761 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.7 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | -0.85 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P62987 | UBA52 | Ubiquitin-60S ribosomal protein L40 | 0.772 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.791 | O14976 | GAK | Cyclin-G-associated kinase | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.773 | Q8NI60 | CABC1 | Atypical kinase COQ8A, mitochondrial | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.758 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.736 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P43686 | PSMC4 | 26S proteasome regulatory subunit 6B | -0.729 |
| Tofacitinib | hsa05030 | Cocaine addiction | 5.99E-03 | 3 | Q00535, Q99941, P18848 | CDK5, CREBL1, ATF4 | More | | Tofacitinib | hsa05031 | Amphetamine addiction | 4.45E-05 | 5 | P0DP24, P0DP23, Q13557, Q99941, P18848 | CALM2, CALM1, CAMK2D, CREBL1, ATF4 | More | | Tofacitinib | hsa05032 | Morphine addiction | 5.68E-03 | 2 | P78334, P32298 | GABRE, GRK4 | More | | Tofacitinib | hsa05033 | Nicotine addiction | 4.01E-02 | 1 | P78334 | GABRE | More | | Tofacitinib | hsa05034 | Alcoholism | 4.25E-04 | 10 | Q99941, P18848, Q13547, P0DP24, P62873, P61952, P04049, P0C0S5, P62807, Q16778 | CREBL1, ATF4, HDAC1, CALM2, GNB1, GNG11, RAF1, H2AFZ, HIST1H2BC, HIST2H2BE | More | | Tofacitinib | hsa05100 | Bacterial invasion of epithelial cells | 3.14E-03 | 3 | Q14141, Q05397, Q96JJ3 | SEPT6, PTK2, ELMO2 | More | | Tofacitinib | hsa05110 | Vibrio cholerae infection | 2.11E-03 | 2 | Q99437, P17612 | ATP6V0B, PRKACA | More | | Tofacitinib | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.55E-10 | 10 | Q16539, Q99437, Q13153, P09341, P19875, P10145, P19174, P25024, P25025, P41240 | MAPK14, ATP6V0B, PAK1, CXCL1, CXCL2, IL8, PLCG1, CXCR1, CXCR2, CSK | More | | Tofacitinib | hsa05130 | Pathogenic Escherichia coli infection | 2.77E-03 | 9 | P16333, Q13509, P60709, P25963, P04406, P29350, Q15438, P35579, P55061 | NCK1, TUBB3, ACTB, NFKBIA, GAPDH, PTPN6, PSCD1, MYH9, TEGT | More | | Tofacitinib | hsa05131 | Shigellosis | 3.55E-06 | 18 | Q12933, Q13546, P68431, Q05655, Q02156, Q9UDY8, Q9NQL2, P0CG47, Q14141, Q14247, Q96JJ3, Q05397, Q14643, Q12778, Q13315, P10415, Q08752, P07737 | TRAF2, RIPK1, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, PRKCD, PRKCE, MALT1, RRAGD, UBB, SEPT6, CTTN, ELMO2, PTK2, ITPR1, FOXO1, ATM, BCL2, PPID, PFN1 | More | | Tofacitinib | hsa05132 | Salmonella infection | 1.26E-09 | 20 | P51617, P25963, P08238, P04049, Q9UJU2, P01106, P84095, P60709, Q13546, Q13489, P10415, P04406, O75369, P07737, O60603, Q9BQS8, Q13561, Q13509, P68371, P49754 | IRAK1, NFKBIA, HSP90AB1, RAF1, LEF1, MYC, RHOG, ACTB, RIPK1, BIRC3, BCL2, GAPDH, FLNB, PFN1, TLR2, FYCO1, DCTN2, TUBB3, TUBB2C, VPS41 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | 1 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.789 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.833 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | -0.72 | P17252 | PRKCA | Protein kinase C alpha type | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | 0.881 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | 0.768 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P01106 | MYC | Myc proto-oncogene protein | -0.717 | Q05655 | PRKCD | Protein kinase C delta type | P84095 | RHOG | Rho-related GTP-binding protein RhoG | 0.71 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P60709 | ACTB | Actin, cytoplasmic 1 | -0.792 | Q07912 | TNK2 | Activated CDC42 kinase 1 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | 0.702 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | 1 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.788 | P17252 | PRKCA | Protein kinase C alpha type | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.849 | Q07912 | TNK2 | Activated CDC42 kinase 1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.7 | P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.807 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P04406 | GAPDH | Glyceraldehyde-3-phosphate dehydrogenase | -0.796 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | O75369 | FLNB | Filamin-B | -0.713 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | O75369 | FLNB | Filamin-B | -0.82 | Q05655 | PRKCD | Protein kinase C delta type | P07737 | PFN1 | Profilin-1 | 0.77 | P17252 | PRKCA | Protein kinase C alpha type | O60603 | TLR2 | Toll-like receptor 2 | -0.716 | P17252 | PRKCA | Protein kinase C alpha type | Q9BQS8 | FYCO1 | FYVE and coiled-coil domain-containing protein 1 | 0.701 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | Q9BQS8 | FYCO1 | FYVE and coiled-coil domain-containing protein 1 | 0.812 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | Q13561 | DCTN2 | Dynactin subunit 2 | 0.754 | P17252 | PRKCA | Protein kinase C alpha type | Q13561 | DCTN2 | Dynactin subunit 2 | -0.844 | Q07912 | TNK2 | Activated CDC42 kinase 1 | Q13509 | TUBB3 | Tubulin beta-3 chain | 0.745 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | Q13509 | TUBB3 | Tubulin beta-3 chain | 0.735 | P17252 | PRKCA | Protein kinase C alpha type | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.756 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.757 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.791 | Q07912 | TNK2 | Activated CDC42 kinase 1 | P68371 | TUBB2C | Tubulin beta-4B chain | 0.854 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | P68371 | TUBB2C | Tubulin beta-4B chain | 0.748 | P17252 | PRKCA | Protein kinase C alpha type | P68371 | TUBB2C | Tubulin beta-4B chain | -0.842 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P49754 | VPS41 | Vacuolar protein sorting-associated protein 41 homolog | -0.764 |
| Tofacitinib | hsa05133 | Pertussis | 1.43E-05 | 3 | P05107, P10145, P0C0L4 | ITGB2, IL8, C4A | More | | Tofacitinib | hsa05134 | Legionellosis | 2.58E-08 | 9 | P01584, P25963, Q9NR31, P11215, P68104, P0DMV8, P11142, P09341, P19875 | IL1B, NFKBIA, SAR1A, ITGAM, EEF1A1, HSPA1A, HSPA8, CXCL1, CXCL2 | More | | Tofacitinib | hsa05135 | Yersinia infection | 1.86E-04 | 8 | Q05397, P51812, P06239, P19174, Q02750, P42338, Q96JJ3, P01732 | PTK2, RPS6KA3, LCK, PLCG1, MAP2K1, PIK3CB, ELMO2, CD8A | More | | Tofacitinib | hsa05140 | Leishmaniasis | 1.39E-08 | 13 | P13612, O75015, P14598, P11215, P42224, P13765, O60603, P25963, P01375, P29350, P49006, Q16539, Q15080 | ITGA4, FCGR3B, NCF1, ITGAM, STAT1, HLA-DOB, TLR2, NFKBIA, TNF, PTPN6, MARCKSL1, MAPK14, NCF4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13612 | ITGA4 | Integrin alpha-4 | 0.774 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.814 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | -0.778 | P17252 | PRKCA | Protein kinase C alpha type | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.821 | P49336 | CDK8 | Cyclin-dependent kinase 8 | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.721 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.759 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P11215 | ITGAM | Integrin alpha-M | 0.757 | P17252 | PRKCA | Protein kinase C alpha type | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.706 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.77 | P17252 | PRKCA | Protein kinase C alpha type | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.709 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.754 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.85 | P17252 | PRKCA | Protein kinase C alpha type | O60603 | TLR2 | Toll-like receptor 2 | -0.716 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O60603 | TLR2 | Toll-like receptor 2 | 0.73 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O60603 | TLR2 | Toll-like receptor 2 | -0.714 | P49336 | CDK8 | Cyclin-dependent kinase 8 | O60603 | TLR2 | Toll-like receptor 2 | -0.734 | P49336 | CDK8 | Cyclin-dependent kinase 8 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.728 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.789 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | P17252 | PRKCA | Protein kinase C alpha type | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | -0.754 | P49336 | CDK8 | Cyclin-dependent kinase 8 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | -0.726 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | -0.815 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P49006 | MARCKSL1 | MARCKS-related protein | -0.852 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | P17252 | PRKCA | Protein kinase C alpha type | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.836 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.74 | P49336 | CDK8 | Cyclin-dependent kinase 8 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.754 |
| Tofacitinib | hsa05142 | Chagas disease | 2.70E-02 | 2 | P48023, Q14790 | FASLG, CASP8 | More | | Tofacitinib | hsa05143 | African trypanosomiasis | 2.11E-03 | 2 | P69905, P68871 | HBA2, HBB | More | | Tofacitinib | hsa05144 | Malaria | 6.72E-05 | 9 | P60033, P69905, P68871, O60603, P01375, P05107, P35443, P10145, P26718 | CD81, HBA2, HBB, TLR2, TNF, ITGB2, THBS4, IL8, KLRK1 | More | | Tofacitinib | hsa05145 | Toxoplasmosis | 1.11E-02 | 6 | P10415, Q13489, P42224, P13765, O60603, P29965 | BCL2, BIRC3, STAT1, HLA-DOB, TLR2, CD40LG | More | | Tofacitinib | hsa05146 | Amoebiasis | 1.14E-14 | 12 | P09341, P19875, P14778, P27930, P01375, O60603, P42338, P11215, P05089, P22694, P12814, P08311 | CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ITGAM, ARG1, PRKACB, ACTN1, CTSG | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42681 | TXK | Tyrosine-protein kinase TXK | P09341 | CXCL1 | Growth-regulated alpha protein | -0.881 | Q04759 | PRKCQ | Protein kinase C theta type | P09341 | CXCL1 | Growth-regulated alpha protein | -0.885 | P24723 | PRKCH | Protein kinase C eta type | P09341 | CXCL1 | Growth-regulated alpha protein | -0.707 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P09341 | CXCL1 | Growth-regulated alpha protein | -0.826 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.7 | P06239 | LCK | Tyrosine-protein kinase Lck | P09341 | CXCL1 | Growth-regulated alpha protein | -0.805 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09341 | CXCL1 | Growth-regulated alpha protein | -0.802 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.927 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P09341 | CXCL1 | Growth-regulated alpha protein | 0.78 | P24723 | PRKCH | Protein kinase C eta type | P19875 | CXCL2 | C-X-C motif chemokine 2 | -0.853 | P24723 | PRKCH | Protein kinase C eta type | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.705 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | P06239 | LCK | Tyrosine-protein kinase Lck | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.782 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.854 | Q04759 | PRKCQ | Protein kinase C theta type | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.733 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.811 | P06239 | LCK | Tyrosine-protein kinase Lck | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.779 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.727 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.813 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.824 | Q04759 | PRKCQ | Protein kinase C theta type | P01375 | TNF | Tumor necrosis factor | -0.725 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P01375 | TNF | Tumor necrosis factor | -0.813 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P01375 | TNF | Tumor necrosis factor | -0.783 | P42681 | TXK | Tyrosine-protein kinase TXK | O60603 | TLR2 | Toll-like receptor 2 | -0.714 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O60603 | TLR2 | Toll-like receptor 2 | 0.73 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O60603 | TLR2 | Toll-like receptor 2 | -0.714 | P24723 | PRKCH | Protein kinase C eta type | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.79 | P24723 | PRKCH | Protein kinase C eta type | P11215 | ITGAM | Integrin alpha-M | -0.7 | P42681 | TXK | Tyrosine-protein kinase TXK | P05089 | ARG1 | Arginase-1 | -0.739 | Q04759 | PRKCQ | Protein kinase C theta type | P05089 | ARG1 | Arginase-1 | -0.899 | P24723 | PRKCH | Protein kinase C eta type | P05089 | ARG1 | Arginase-1 | -0.749 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P05089 | ARG1 | Arginase-1 | -0.791 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05089 | ARG1 | Arginase-1 | 0.702 | P06239 | LCK | Tyrosine-protein kinase Lck | P05089 | ARG1 | Arginase-1 | -0.803 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P05089 | ARG1 | Arginase-1 | -0.868 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P05089 | ARG1 | Arginase-1 | -0.905 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P05089 | ARG1 | Arginase-1 | 0.875 | P42681 | TXK | Tyrosine-protein kinase TXK | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | 0.878 | Q04759 | PRKCQ | Protein kinase C theta type | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | 0.755 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | 1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | 0.873 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | 0.894 | Q04759 | PRKCQ | Protein kinase C theta type | P12814 | ACTN1 | Alpha-actinin-1 | -0.821 | P24723 | PRKCH | Protein kinase C eta type | P12814 | ACTN1 | Alpha-actinin-1 | -0.869 | P06239 | LCK | Tyrosine-protein kinase Lck | P12814 | ACTN1 | Alpha-actinin-1 | -0.867 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P12814 | ACTN1 | Alpha-actinin-1 | -0.76 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P12814 | ACTN1 | Alpha-actinin-1 | 0.794 | P42681 | TXK | Tyrosine-protein kinase TXK | P08311 | CTSG | Cathepsin G | -0.83 | Q04759 | PRKCQ | Protein kinase C theta type | P08311 | CTSG | Cathepsin G | -0.913 | P24723 | PRKCH | Protein kinase C eta type | P08311 | CTSG | Cathepsin G | -0.744 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P08311 | CTSG | Cathepsin G | -0.847 | P06239 | LCK | Tyrosine-protein kinase Lck | P08311 | CTSG | Cathepsin G | -0.816 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P08311 | CTSG | Cathepsin G | -0.866 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P08311 | CTSG | Cathepsin G | -0.898 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P08311 | CTSG | Cathepsin G | 0.768 |
| Tofacitinib | hsa05150 | Staphylococcus aureus infection | 1.11E-09 | 15 | P09871, P0C0L4, P21730, P21462, O75015, P31995, P13765, P13646, Q14532, P05107, P16109, P59665, P59666, P12838, P49913 | C1S, C4A, C5AR1, FPR1, FCGR3B, FCGR2C, HLA-DOB, KRT13, KRT32, ITGB2, SELP, DEFA1; DEFA1B, DEFA3, DEFA4, CAMP | More | | Tofacitinib | hsa05152 | Tuberculosis | 2.08E-06 | 12 | P04049, Q13488, P0DP23, P42224, P48382, O60603, P31751, P10415, P13765, P01568, Q9UDY8, P51617 | RAF1, TCIRG1, CALM1, STAT1, RFX5, TLR2, AKT2, BCL2, HLA-DOB, IFNA21, MALT1, IRAK1 | More | | Tofacitinib | hsa05160 | Hepatitis C | 2.32E-03 | 3 | Q13546, P01568, P04049 | RIPK1, IFNA21, RAF1 | More | | Tofacitinib | hsa05161 | Hepatitis B | 4.32E-03 | 4 | P04049, Q99941, P18848, P27348 | RAF1, CREBL1, ATF4, YWHAQ | More | | Tofacitinib | hsa05162 | Measles | 5.20E-04 | 6 | P23458, P31751, P0DMV8, P01584, P67870, Q9NP90 | JAK1, AKT2, HSPA1A, IL1B, CSNK2B, RAB9B | More | | Tofacitinib | hsa05163 | Human cytomegalovirus infection | 1.28E-10 | 24 | P31751, P04049, P01375, P62873, P50151, P61952, Q14643, P0DP23, P0DP24, Q8NHW4, Q08828, P51828, P23458, P49841, P14778, P01584, Q13651, P25025, Q16539, Q99941, P18848, P04637, O00463, P61769 | AKT2, RAF1, TNF, GNB1, GNG10, GNG11, ITPR1, CALM1, CALM2, CCL4L2, ADCY1, ADCY7, JAK1, GSK3B, IL1R1, IL1B, IL10RA, CXCR2, MAPK14, CREBL1, ATF4, TP53, TRAF5, B2M | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O14976 | GAK | Cyclin-G-associated kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.703 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.726 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 1 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P01375 | TNF | Tumor necrosis factor | 0.732 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.789 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.766 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P61952 | GNG11 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 | -0.756 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | -0.728 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P0DP23 | CALM1 | Calmodulin-1 | 0.822 | O14976 | GAK | Cyclin-G-associated kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.811 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P0DP23 | CALM1 | Calmodulin-1 | 0.857 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P0DP24 | CALM2 | Calmodulin-2 | 0.786 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.761 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.756 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.756 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.84 | O14976 | GAK | Cyclin-G-associated kinase | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.787 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.796 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.75 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.834 | O14976 | GAK | Cyclin-G-associated kinase | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.753 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.726 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 1 | O14976 | GAK | Cyclin-G-associated kinase | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.845 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.842 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.78 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 1 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.733 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.778 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.854 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P01584 | IL1B | Interleukin-1 beta | 0.799 | O14976 | GAK | Cyclin-G-associated kinase | P01584 | IL1B | Interleukin-1 beta | 0.742 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P01584 | IL1B | Interleukin-1 beta | 0.735 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P01584 | IL1B | Interleukin-1 beta | 0.725 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | 0.799 | O14976 | GAK | Cyclin-G-associated kinase | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | 0.795 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | 0.786 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | -0.797 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.889 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.861 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.774 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.78 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.802 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.801 | O14976 | GAK | Cyclin-G-associated kinase | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.716 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.748 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.844 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P04637 | TP53 | Cellular tumor antigen p53 | -0.823 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.837 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.734 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.735 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | P61769 | B2M | Beta-2-microglobulin | 0.753 |
| Tofacitinib | hsa05164 | Influenza A | 1.49E-02 | 6 | P31751, P01584, P23458, P05141, P04049, Q9UBU9 | AKT2, IL1B, JAK1, SLC25A5, RAF1, NXF1 | More | | Tofacitinib | hsa05165 | Human papillomavirus infection | 7.06E-05 | 17 | P16144, P02452, P24821, Q16363, Q05086, P30281, Q9UM47, P01568, P42224, P01889, P10321, Q13488, Q99437, Q13362, Q12778, P04628, Q13315 | ITGB4, COL1A1, TNC, LAMA4, UBE3A, CCND3, NOTCH3, IFNA21, STAT1, HLA-B, HLA-C, TCIRG1, ATP6V0B, PPP2R5C, FOXO1, WNT1, ATM | More | | Tofacitinib | hsa05166 | Human T-cell leukemia virus 1 infection | 3.90E-02 | 7 | P23458, P05141, P62826, Q08828, P51828, P18848, P31751 | JAK1, SLC25A5, RAN, ADCY1, ADCY7, ATF4, AKT2 | More | | Tofacitinib | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 8.92E-05 | 11 | P01568, P31751, P42224, P25963, P62873, P19174, Q14643, P04049, P01106, P0DP23, Q9UJU2 | IFNA21, AKT2, STAT1, NFKBIA, GNB1, PLCG1, ITPR1, RAF1, MYC, CALM1, LEF1 | More | | Tofacitinib | hsa05168 | Herpes simplex virus 1 infection | 2.25E-04 | 21 | O00463, O60603, P25963, Q05823, P42224, Q07955, Q01130, Q13243, Q16629, P42338, Q9Y2A4, Q13398, P51522, Q9NR11, P17097, P17038, Q03923, P52738, O75820, Q9UDV6, P10415 | TRAF5, TLR2, NFKBIA, RNASEL, STAT1, SFRS1, SFRS2, SFRS5, SFRS7, PIK3CB, ZNF443, ZNF211, ZNF83, ZNF302, ZNF7, ZNF43, ZNF85, ZNF140, ZNF189, ZNF212, BCL2 | More | | Tofacitinib | hsa05169 | Epstein-Barr virus infection | 1.72E-06 | 17 | P13765, P01106, Q13547, O00463, P10415, P42338, P07948, Q13761, P24522, O75293, P42224, P01375, O60603, P29728, P07766, P09693, P20963 | HLA-DOB, MYC, HDAC1, TRAF5, BCL2, PIK3CB, LYN, RUNX3, GADD45A, GADD45B, STAT1, TNF, TLR2, OAS2, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42681 | TXK | Tyrosine-protein kinase TXK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.89 | Q04759 | PRKCQ | Protein kinase C theta type | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.82 | P06239 | LCK | Tyrosine-protein kinase Lck | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.777 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | P01106 | MYC | Myc proto-oncogene protein | -0.788 | P06239 | LCK | Tyrosine-protein kinase Lck | P01106 | MYC | Myc proto-oncogene protein | 0.719 | Q04759 | PRKCQ | Protein kinase C theta type | Q13547 | HDAC1 | Histone deacetylase 1 | 0.723 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Q13547 | HDAC1 | Histone deacetylase 1 | -0.774 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | Q13547 | HDAC1 | Histone deacetylase 1 | -0.731 | P06239 | LCK | Tyrosine-protein kinase Lck | Q13547 | HDAC1 | Histone deacetylase 1 | 0.811 | P42681 | TXK | Tyrosine-protein kinase TXK | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.827 | Q04759 | PRKCQ | Protein kinase C theta type | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.81 | P06239 | LCK | Tyrosine-protein kinase Lck | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.718 | P42681 | TXK | Tyrosine-protein kinase TXK | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.716 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.735 | P06239 | LCK | Tyrosine-protein kinase Lck | P07948 | LYN | Tyrosine-protein kinase Lyn | -0.701 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Q13761 | RUNX3 | Runt-related transcription factor 3 | -0.708 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | Q13761 | RUNX3 | Runt-related transcription factor 3 | -0.713 | P06239 | LCK | Tyrosine-protein kinase Lck | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.85 | P42681 | TXK | Tyrosine-protein kinase TXK | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.79 | Q04759 | PRKCQ | Protein kinase C theta type | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.846 | P06239 | LCK | Tyrosine-protein kinase Lck | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.724 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.768 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.723 | Q04759 | PRKCQ | Protein kinase C theta type | P01375 | TNF | Tumor necrosis factor | -0.725 | P42681 | TXK | Tyrosine-protein kinase TXK | O60603 | TLR2 | Toll-like receptor 2 | -0.714 | P42681 | TXK | Tyrosine-protein kinase TXK | P29728 | OAS2 | 2'-5'-oligoadenylate synthase 2 | 0.831 | Q04759 | PRKCQ | Protein kinase C theta type | P29728 | OAS2 | 2'-5'-oligoadenylate synthase 2 | 0.875 | Q04759 | PRKCQ | Protein kinase C theta type | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.713 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.77 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.779 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | P42681 | TXK | Tyrosine-protein kinase TXK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.838 | Q04759 | PRKCQ | Protein kinase C theta type | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.756 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | P42681 | TXK | Tyrosine-protein kinase TXK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.811 | Q04759 | PRKCQ | Protein kinase C theta type | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.92 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 |
| Tofacitinib | hsa05170 | Human immunodeficiency virus 1 infection | 4.56E-08 | 16 | P31751, P04049, Q02750, P62873, P62879, P16298, P0DP23, Q05397, P17252, Q14643, P01568, P51617, O60603, Q13315, P10415, Q9Y6Q5 | AKT2, RAF1, MAP2K1, GNB1, GNB2, PPP3CB, CALM1, PTK2, PRKCA, ITPR1, IFNA21, IRAK1, TLR2, ATM, BCL2, AP1M2 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 1 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.93 | Q13873 | BMPR2 | Bone morphogenetic protein receptor type-2 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.852 | P17252 | PRKCA | Protein kinase C alpha type | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.852 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.759 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | P62879 | GNB2 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 | 0.96 | Q13873 | BMPR2 | Bone morphogenetic protein receptor type-2 | P62879 | GNB2 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 | 0.826 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.93 | Q13873 | BMPR2 | Bone morphogenetic protein receptor type-2 | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.775 | P17252 | PRKCA | Protein kinase C alpha type | P0DP23 | CALM1 | Calmodulin-1 | -0.776 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P0DP23 | CALM1 | Calmodulin-1 | -0.703 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.761 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | Q05397 | PTK2 | Focal adhesion kinase 1 | 0.932 | Q13873 | BMPR2 | Bone morphogenetic protein receptor type-2 | Q05397 | PTK2 | Focal adhesion kinase 1 | 0.806 | P17252 | PRKCA | Protein kinase C alpha type | P17252 | PRKCA | Protein kinase C alpha type | 1 | P17252 | PRKCA | Protein kinase C alpha type | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.786 | P17252 | PRKCA | Protein kinase C alpha type | P01568 | IFNA21 | Interferon alpha-21 | 0.733 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | 1 | P17252 | PRKCA | Protein kinase C alpha type | O60603 | TLR2 | Toll-like receptor 2 | -0.716 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | Q13315 | ATM | Serine-protein kinase ATM | -0.748 | P17252 | PRKCA | Protein kinase C alpha type | Q13315 | ATM | Serine-protein kinase ATM | 0.739 | P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.807 | P17252 | PRKCA | Protein kinase C alpha type | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | -0.829 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | -0.814 |
| Tofacitinib | hsa05171 | Coronavirus disease - COVID-19 | 4.96E-11 | 21 | P01584, P23396, P62753, P25398, P42677, P36578, Q02878, P62917, P32969, P27635, P26373, Q07020, P62888, P46776, P62899, P62910, P18077, P61927, P61513, P05386, P62829 | IL1B, RPS3, RPS6, RPS12, RPS27, RPL4, RPL6, RPL8, RPL9, RPL10, RPL13, RPL18, RPL30, RPL27A, RPL31, RPL32, RPL35A, RPL37, RPL37A, RPLP1, RPL23 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O00141 | SGK | Serine/threonine-protein kinase Sgk1 | P01584 | IL1B | Interleukin-1 beta | 0.786 | Q9NQU5 | PAK6 | Serine/threonine-protein kinase PAK 6 | P23396 | RPS3 | 40S ribosomal protein S3 | 0.803 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P23396 | RPS3 | 40S ribosomal protein S3 | 0.899 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | P62753 | RPS6 | 40S ribosomal protein S6 | 0.736 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P62753 | RPS6 | 40S ribosomal protein S6 | 0.716 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P62753 | RPS6 | 40S ribosomal protein S6 | 0.716 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P25398 | RPS12 | 40S ribosomal protein S12 | 0.784 | Q9NQU5 | PAK6 | Serine/threonine-protein kinase PAK 6 | P42677 | RPS27 | 40S ribosomal protein S27 | 0.731 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P42677 | RPS27 | 40S ribosomal protein S27 | 0.819 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | P36578 | RPL4 | 60S ribosomal protein L4 | 0.725 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P36578 | RPL4 | 60S ribosomal protein L4 | 0.74 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P36578 | RPL4 | 60S ribosomal protein L4 | 0.873 | Q9NQU5 | PAK6 | Serine/threonine-protein kinase PAK 6 | Q02878 | RPL6 | 60S ribosomal protein L6 | 0.762 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | Q02878 | RPL6 | 60S ribosomal protein L6 | 0.795 | Q9NQU5 | PAK6 | Serine/threonine-protein kinase PAK 6 | P62917 | RPL8 | 60S ribosomal protein L8 | 0.824 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P62917 | RPL8 | 60S ribosomal protein L8 | 0.813 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P32969 | RPL9 | 60S ribosomal protein L9 | 0.78 | Q9NQU5 | PAK6 | Serine/threonine-protein kinase PAK 6 | P27635 | RPL10 | 60S ribosomal protein L10 | 0.715 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P27635 | RPL10 | 60S ribosomal protein L10 | 0.73 | Q9NQU5 | PAK6 | Serine/threonine-protein kinase PAK 6 | P26373 | RPL13 | 60S ribosomal protein L13 | 0.752 | Q9NQU5 | PAK6 | Serine/threonine-protein kinase PAK 6 | Q07020 | RPL18 | 60S ribosomal protein L18 | 0.74 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | Q07020 | RPL18 | 60S ribosomal protein L18 | 0.778 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | P62888 | RPL30 | 60S ribosomal protein L30 | 0.725 | Q9NQU5 | PAK6 | Serine/threonine-protein kinase PAK 6 | P46776 | RPL27A | 60S ribosomal protein L27a | 0.719 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P46776 | RPL27A | 60S ribosomal protein L27a | 0.716 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P46776 | RPL27A | 60S ribosomal protein L27a | 0.79 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P62899 | RPL31 | 60S ribosomal protein L31 | 0.753 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P62910 | RPL32 | 60S ribosomal protein L32 | 0.704 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P18077 | RPL35A | 60S ribosomal protein L35a | 0.833 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | P61927 | RPL37 | 60S ribosomal protein L37 | 0.761 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P61927 | RPL37 | 60S ribosomal protein L37 | 0.709 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | P61513 | RPL37A | 60S ribosomal protein L37a | 0.728 | Q9NQU5 | PAK6 | Serine/threonine-protein kinase PAK 6 | P05386 | RPLP1 | 60S acidic ribosomal protein P1 | 0.77 | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | P05386 | RPLP1 | 60S acidic ribosomal protein P1 | 0.837 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | P62829 | RPL23 | 60S ribosomal protein L23 | 0.726 |
| Tofacitinib | hsa05200 | Pathways in cancer | 1.47E-07 | 32 | P42338, P08238, P42224, P25963, P19174, P01106, Q9UJU2, P17252, P43246, Q13485, P20585, P52701, P14923, P30279, P10415, Q13489, Q13077, P49767, P14921, Q12778, P31751, P25116, P62873, P63218, Q9UM47, P78417, O75293, P0DP23, P01568, P14784, P40189, P01042 | PIK3CB, HSP90AB1, STAT1, NFKBIA, PLCG1, MYC, LEF1, PRKCA, MSH2, SMAD4, MSH3, MSH6, JUP, CCND2, BCL2, BIRC3, TRAF1, VEGFC, ETS1, FOXO1, AKT2, F2R, GNB1, GNG5, NOTCH3, GSTO1, GADD45B, CALM1, IFNA21, IL2RB, IL6ST, KNG1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P29375 | JARID1A | Lysine-specific demethylase 5A | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.79 | P29375 | JARID1A | Lysine-specific demethylase 5A | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.711 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.833 | P17252 | PRKCA | Protein kinase C alpha type | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.706 | P29375 | JARID1A | Lysine-specific demethylase 5A | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.764 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.77 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.789 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.888 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P01106 | MYC | Myc proto-oncogene protein | -0.717 | P17252 | PRKCA | Protein kinase C alpha type | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | 0.881 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | 0.768 | P17252 | PRKCA | Protein kinase C alpha type | P17252 | PRKCA | Protein kinase C alpha type | 1 | P29375 | JARID1A | Lysine-specific demethylase 5A | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.87 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.744 | O43318 | MAP3K7 | Mitogen-activated protein kinase kinase kinase 7 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.794 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P20585 | MSH3 | DNA mismatch repair protein Msh3 | -0.729 | O43318 | MAP3K7 | Mitogen-activated protein kinase kinase kinase 7 | P52701 | MSH6 | DNA mismatch repair protein Msh6 | 0.91 | P17252 | PRKCA | Protein kinase C alpha type | P14923 | JUP | Junction plakoglobin | 0.761 | P29375 | JARID1A | Lysine-specific demethylase 5A | P14923 | JUP | Junction plakoglobin | -0.735 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P14923 | JUP | Junction plakoglobin | 0.766 | O43318 | MAP3K7 | Mitogen-activated protein kinase kinase kinase 7 | P30279 | CCND2 | G1/S-specific cyclin-D2 | 0.704 | P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.807 | P17252 | PRKCA | Protein kinase C alpha type | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.849 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.801 | P17252 | PRKCA | Protein kinase C alpha type | P49767 | VEGFC | Vascular endothelial growth factor C | 0.719 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P14921 | ETS1 | Protein C-ets-1 | -0.764 | P17252 | PRKCA | Protein kinase C alpha type | Q12778 | FOXO1 | Forkhead box protein O1 | 0.863 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 1 | P17252 | PRKCA | Protein kinase C alpha type | P25116 | F2R | Proteinase-activated receptor 1 | 0.857 | P17252 | PRKCA | Protein kinase C alpha type | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.852 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.759 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.862 | O43318 | MAP3K7 | Mitogen-activated protein kinase kinase kinase 7 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.707 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | Q9UM47 | NOTCH3 | Neurogenic locus notch homolog protein 3 | -0.71 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | Q9UM47 | NOTCH3 | Neurogenic locus notch homolog protein 3 | -0.719 | O43318 | MAP3K7 | Mitogen-activated protein kinase kinase kinase 7 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.849 | P29375 | JARID1A | Lysine-specific demethylase 5A | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.748 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.86 | P17252 | PRKCA | Protein kinase C alpha type | P0DP23 | CALM1 | Calmodulin-1 | -0.776 | P29375 | JARID1A | Lysine-specific demethylase 5A | P0DP23 | CALM1 | Calmodulin-1 | 0.755 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P0DP23 | CALM1 | Calmodulin-1 | -0.703 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P0DP23 | CALM1 | Calmodulin-1 | -0.826 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.761 | P17252 | PRKCA | Protein kinase C alpha type | P01568 | IFNA21 | Interferon alpha-21 | 0.733 | P29375 | JARID1A | Lysine-specific demethylase 5A | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.768 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.736 | P29375 | JARID1A | Lysine-specific demethylase 5A | P40189 | IL6ST | Interleukin-6 receptor subunit beta | 0.83 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P01042 | KNG1 | Kininogen-1 | 0.763 |
| Tofacitinib | hsa05202 | Transcriptional misregulation in cancer | 5.74E-08 | 18 | Q12778, Q13315, P41732, P14780, P27930, Q15744, Q16548, Q13077, O15550, P08069, P35226, P05164, P12838, P08246, Q9C0K0, Q13547, P12980, P24522 | FOXO1, ATM, TSPAN7, MMP9, IL1R2, CEBPE, BCL2A1, TRAF1, UTX, IGF1R, BMI1, MPO, DEFA4, ELA2, BCL11B, HDAC1, LYL1, GADD45A | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q12778 | FOXO1 | Forkhead box protein O1 | 0.716 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q13315 | ATM | Serine-protein kinase ATM | 0.858 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13315 | ATM | Serine-protein kinase ATM | 0.752 | P42681 | TXK | Tyrosine-protein kinase TXK | P41732 | TSPAN7 | Tetraspanin-7 | -0.719 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P41732 | TSPAN7 | Tetraspanin-7 | -0.733 | P42681 | TXK | Tyrosine-protein kinase TXK | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.762 | Q04759 | PRKCQ | Protein kinase C theta type | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.787 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.826 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.855 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.869 | Q04759 | PRKCQ | Protein kinase C theta type | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.733 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.727 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.813 | Q04759 | PRKCQ | Protein kinase C theta type | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | -0.745 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | -0.779 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | -0.833 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | -0.844 | P42681 | TXK | Tyrosine-protein kinase TXK | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.756 | Q04759 | PRKCQ | Protein kinase C theta type | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.76 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.769 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.877 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.762 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.83 | P42681 | TXK | Tyrosine-protein kinase TXK | O15550 | UTX | Lysine-specific demethylase 6A | -0.731 | P08069 | IGF1R | Insulin-like growth factor 1 receptor | P08069 | IGF1R | Insulin-like growth factor 1 receptor | 1 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.759 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.76 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.759 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.76 | P42681 | TXK | Tyrosine-protein kinase TXK | P05164 | MPO | Myeloperoxidase | -0.829 | Q04759 | PRKCQ | Protein kinase C theta type | P05164 | MPO | Myeloperoxidase | -0.88 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P05164 | MPO | Myeloperoxidase | -0.817 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P05164 | MPO | Myeloperoxidase | -0.811 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P05164 | MPO | Myeloperoxidase | -0.867 | P42681 | TXK | Tyrosine-protein kinase TXK | P12838 | DEFA4 | Neutrophil defensin 4 | -0.707 | Q04759 | PRKCQ | Protein kinase C theta type | P12838 | DEFA4 | Neutrophil defensin 4 | -0.833 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P12838 | DEFA4 | Neutrophil defensin 4 | -0.796 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P12838 | DEFA4 | Neutrophil defensin 4 | -0.86 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P12838 | DEFA4 | Neutrophil defensin 4 | -0.852 | P42681 | TXK | Tyrosine-protein kinase TXK | P08246 | ELA2 | Neutrophil elastase | -0.756 | Q04759 | PRKCQ | Protein kinase C theta type | P08246 | ELA2 | Neutrophil elastase | -0.748 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P08246 | ELA2 | Neutrophil elastase | -0.772 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P08246 | ELA2 | Neutrophil elastase | -0.782 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P08246 | ELA2 | Neutrophil elastase | -0.742 | P42681 | TXK | Tyrosine-protein kinase TXK | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.874 | Q04759 | PRKCQ | Protein kinase C theta type | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.774 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.807 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.9 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.822 | Q04759 | PRKCQ | Protein kinase C theta type | Q13547 | HDAC1 | Histone deacetylase 1 | 0.723 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q13547 | HDAC1 | Histone deacetylase 1 | 0.83 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P12980 | LYL1 | Protein lyl-1 | -0.73 | P42681 | TXK | Tyrosine-protein kinase TXK | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.79 | Q04759 | PRKCQ | Protein kinase C theta type | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.846 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.75 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.787 |
| Tofacitinib | hsa05203 | Viral carcinogenesis | 4.16E-05 | 13 | Q12933, Q99941, P18848, P30281, P27348, Q13547, P06396, P12814, P01889, P10321, P06493, P62807, Q16778 | TRAF2, CREBL1, ATF4, CCND3, YWHAQ, HDAC1, GSN, ACTN1, HLA-B, HLA-C, CDK1, HIST1H2BC, HIST2H2BE | More | | Tofacitinib | hsa05205 | Proteoglycans in cancer | 6.79E-05 | 10 | Q13009, Q12955, O75369, P60709, P04049, P01106, P08069, P19174, P29350, P08962 | TIAM1, ANK3, FLNB, ACTB, RAF1, MYC, IGF1R, PLCG1, PTPN6, CD63 | More | | Tofacitinib | hsa05206 | MicroRNAs in cancer | 3.15E-02 | 1 | P04049 | RAF1 | More | | Tofacitinib | hsa05210 | Colorectal cancer | 1.47E-04 | 9 | Q9UKG1, Q13485, P43246, P04049, P01106, P52701, P20585, P37173, O75293 | APPL1, SMAD4, MSH2, RAF1, MYC, MSH6, MSH3, TGFBR2, GADD45B | More | | Tofacitinib | hsa05211 | Renal cell carcinoma | 5.09E-05 | 3 | Q13153, P31751, P04049 | PAK1, AKT2, RAF1 | More | | Tofacitinib | hsa05212 | Pancreatic cancer | 3.26E-05 | 7 | P42338, P31751, P04049, Q15311, P23458, P42224, O75293 | PIK3CB, AKT2, RAF1, RALBP1, JAK1, STAT1, GADD45B | More | | Tofacitinib | hsa05213 | Endometrial cancer | 8.16E-04 | 2 | P31751, P04049 | AKT2, RAF1 | More | | Tofacitinib | hsa05214 | Glioma | 4.26E-07 | 7 | P08069, P0DP23, P04049, P42338, P31751, P19174, O75293 | IGF1R, CALM1, RAF1, PIK3CB, AKT2, PLCG1, GADD45B | More | | Tofacitinib | hsa05215 | Prostate cancer | 2.34E-04 | 5 | P10415, Q12778, P08069, Q9NRA1, P04049 | BCL2, FOXO1, IGF1R, PDGFC, RAF1 | More | | Tofacitinib | hsa05217 | Basal cell carcinoma | 4.31E-02 | 2 | P04628, Q9UJU2 | WNT1, LEF1 | More | | Tofacitinib | hsa05218 | Melanoma | 5.24E-06 | 3 | P08069, P31751, P04049 | IGF1R, AKT2, RAF1 | More | | Tofacitinib | hsa05219 | Bladder cancer | 5.65E-03 | 3 | P14780, P04637, P04049 | MMP9, TP53, RAF1 | More | | Tofacitinib | hsa05220 | Chronic myeloid leukemia | 9.63E-04 | 2 | P31751, P04049 | AKT2, RAF1 | More | | Tofacitinib | hsa05221 | Acute myeloid leukemia | 8.73E-04 | 5 | P31751, P42338, P04049, Q15744, P11215 | AKT2, PIK3CB, RAF1, CEBPE, ITGAM | More | | Tofacitinib | hsa05222 | Small cell lung cancer | 4.78E-02 | 1 | P31751 | AKT2 | More | | Tofacitinib | hsa05223 | Non-small cell lung cancer | 3.49E-04 | 2 | P31751, P04049 | AKT2, RAF1 | More | | Tofacitinib | hsa05224 | Breast cancer | 2.75E-03 | 6 | P04049, P08069, P49841, Q92837, P04637, P24522 | RAF1, IGF1R, GSK3B, FRAT1, TP53, GADD45A | More | | Tofacitinib | hsa05225 | Hepatocellular carcinoma | 1.65E-04 | 2 | P04049, P08069 | RAF1, IGF1R | More | | Tofacitinib | hsa05226 | Gastric cancer | 6.81E-04 | 2 | P04049, P31751 | RAF1, AKT2 | More | | Tofacitinib | hsa05230 | Central carbon metabolism in cancer | 1.12E-03 | 2 | P04049, P31751 | RAF1, AKT2 | More | | Tofacitinib | hsa05231 | Choline metabolism in cancer | 2.51E-06 | 9 | P04049, P31751, Q9Y259, P19174, P23743, P49619, Q16760, O14986, O14494 | RAF1, AKT2, CHKB, PLCG1, DGKA, DGKG, DGKD, PIP5K1B, PLPP1 | More | | Tofacitinib | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 3.46E-14 | 17 | P25963, P42338, O95267, P19174, P07766, P20963, P09693, P06239, P29350, P04049, P42224, O60603, P10747, Q04759, Q16539, Q9HC35, P01730 | NFKBIA, PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, PTPN6, RAF1, STAT1, TLR2, CD28, PRKCQ, MAPK14, EML4, CD4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.789 | P24723 | PRKCH | Protein kinase C eta type | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.79 | P42681 | TXK | Tyrosine-protein kinase TXK | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.857 | Q04759 | PRKCQ | Protein kinase C theta type | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.733 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.716 | P24723 | PRKCH | Protein kinase C eta type | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.767 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.785 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.888 | Q04759 | PRKCQ | Protein kinase C theta type | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.713 | P24723 | PRKCH | Protein kinase C eta type | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.887 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.779 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.755 | P42681 | TXK | Tyrosine-protein kinase TXK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.811 | Q04759 | PRKCQ | Protein kinase C theta type | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.92 | P24723 | PRKCH | Protein kinase C eta type | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.939 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.778 | P42681 | TXK | Tyrosine-protein kinase TXK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.838 | Q04759 | PRKCQ | Protein kinase C theta type | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.756 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.744 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | P42681 | TXK | Tyrosine-protein kinase TXK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.734 | Q04759 | PRKCQ | Protein kinase C theta type | P06239 | LCK | Tyrosine-protein kinase Lck | 0.779 | P24723 | PRKCH | Protein kinase C eta type | P06239 | LCK | Tyrosine-protein kinase Lck | 0.912 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.827 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P06239 | LCK | Tyrosine-protein kinase Lck | -0.791 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | -0.815 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.723 | Q00536 | PCTK1 | Cyclin-dependent kinase 16 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.77 | P42681 | TXK | Tyrosine-protein kinase TXK | O60603 | TLR2 | Toll-like receptor 2 | -0.714 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O60603 | TLR2 | Toll-like receptor 2 | 0.73 | P42681 | TXK | Tyrosine-protein kinase TXK | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.776 | P42681 | TXK | Tyrosine-protein kinase TXK | Q04759 | PRKCQ | Protein kinase C theta type | 0.876 | Q04759 | PRKCQ | Protein kinase C theta type | Q04759 | PRKCQ | Protein kinase C theta type | 1 | P24723 | PRKCH | Protein kinase C eta type | Q04759 | PRKCQ | Protein kinase C theta type | 0.791 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q04759 | PRKCQ | Protein kinase C theta type | -0.737 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.802 | P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | Q9HC35 | EML4 | Echinoderm microtubule-associated protein-like 4 | 0.716 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.707 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.857 |
| Tofacitinib | hsa05310 | Asthma | 7.64E-08 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Tofacitinib | hsa05320 | Autoimmune thyroid disease | 1.27E-03 | 4 | P13765, P29965, P01568, P10747 | HLA-DOB, CD40LG, IFNA21, CD28 | More | | Tofacitinib | hsa05321 | Inflammatory bowel disease | 6.18E-14 | 7 | O60603, P01375, P13765, Q14765, Q9UL17, P23771, Q9HBE5 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3, IL21R | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42681 | TXK | Tyrosine-protein kinase TXK | O60603 | TLR2 | Toll-like receptor 2 | -0.714 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O60603 | TLR2 | Toll-like receptor 2 | -0.714 | Q04759 | PRKCQ | Protein kinase C theta type | P01375 | TNF | Tumor necrosis factor | -0.725 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P01375 | TNF | Tumor necrosis factor | -0.813 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P01375 | TNF | Tumor necrosis factor | -0.783 | P42681 | TXK | Tyrosine-protein kinase TXK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.89 | Q04759 | PRKCQ | Protein kinase C theta type | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.82 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.76 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.85 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.734 | P42681 | TXK | Tyrosine-protein kinase TXK | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.771 | Q04759 | PRKCQ | Protein kinase C theta type | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.746 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.928 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.904 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.821 | P42681 | TXK | Tyrosine-protein kinase TXK | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.849 | Q04759 | PRKCQ | Protein kinase C theta type | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.843 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.852 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.884 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.858 | P42681 | TXK | Tyrosine-protein kinase TXK | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.856 | Q04759 | PRKCQ | Protein kinase C theta type | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.867 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.715 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.784 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.878 | Q04759 | PRKCQ | Protein kinase C theta type | Q9HBE5 | IL21R | Interleukin-21 receptor | 0.8 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9HBE5 | IL21R | Interleukin-21 receptor | 0.713 |
| Tofacitinib | hsa05322 | Systemic lupus erythematosus | 6.78E-07 | 15 | P08637, O75015, P08246, P08311, P09871, P01375, P10747, P13765, P29965, Q6FI13, P62807, Q16778, P68431, P14678, P12814 | FCGR3A, FCGR3B, ELA2, CTSG, C1S, TNF, CD28, HLA-DOB, CD40LG, H2AC18; H2AC19, HIST1H2BC, HIST2H2BE, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, SNRPB, ACTN1 | More | | Tofacitinib | hsa05323 | Rheumatoid arthritis | 7.52E-06 | 8 | P01375, Q06643, P13765, Q13488, P10747, P09341, P19875, O60603 | TNF, LTB, HLA-DOB, TCIRG1, CD28, CXCL1, CXCL2, TLR2 | More | | Tofacitinib | hsa05330 | Allograft rejection | 9.93E-04 | 4 | P13765, P29965, P10747, P01375 | HLA-DOB, CD40LG, CD28, TNF | More | | Tofacitinib | hsa05332 | Graft-versus-host disease | 3.29E-11 | 5 | P13765, P10747, P01375, P26715, Q13241 | HLA-DOB, CD28, TNF, KLRC1, KLRD1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42681 | TXK | Tyrosine-protein kinase TXK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.89 | Q04759 | PRKCQ | Protein kinase C theta type | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.82 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.76 | P06239 | LCK | Tyrosine-protein kinase Lck | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.777 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.85 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.734 | P42681 | TXK | Tyrosine-protein kinase TXK | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.776 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.79 | Q04759 | PRKCQ | Protein kinase C theta type | P01375 | TNF | Tumor necrosis factor | -0.725 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P01375 | TNF | Tumor necrosis factor | -0.813 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P01375 | TNF | Tumor necrosis factor | -0.783 | P42681 | TXK | Tyrosine-protein kinase TXK | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.901 | Q04759 | PRKCQ | Protein kinase C theta type | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.803 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.972 | P06239 | LCK | Tyrosine-protein kinase Lck | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.756 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.943 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.915 | P42681 | TXK | Tyrosine-protein kinase TXK | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.888 | Q04759 | PRKCQ | Protein kinase C theta type | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.849 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.883 | P06239 | LCK | Tyrosine-protein kinase Lck | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.758 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.852 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.941 |
| Tofacitinib | hsa05340 | Primary immunodeficiency | 2.96E-04 | 6 | P01730, P01732, P11912, Q8WV28, P07766, P06239 | CD4, CD8A, CD79A, BLNK, CD3E, LCK | More | | Tofacitinib | hsa05410 | Hypertrophic cardiomyopathy | 3.63E-02 | 2 | P26012, P09493 | ITGB8, TPM1 | More | | Tofacitinib | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.48E-02 | 1 | P54284 | CACNB3 | More | | Tofacitinib | hsa05414 | Dilated cardiomyopathy | 3.78E-03 | 4 | P54284, P26012, P09493, P26678 | CACNB3, ITGB8, TPM1, PLN | More | | Tofacitinib | hsa05415 | Diabetic cardiomyopathy | 4.77E-04 | 9 | P17252, P30405, P14598, Q15080, Q16718, O14521, Q16539, P14780, P37173 | PRKCA, PPIF, NCF1, NCF4, NDUFA5, SDHD, MAPK14, MMP9, TGFBR2 | More | | Tofacitinib | hsa05416 | Viral myocarditis | 2.62E-02 | 3 | P13765, P29965, P10747 | HLA-DOB, CD40LG, CD28 | More | | Tofacitinib | hsa05418 | Fluid shear stress and atherosclerosis | 1.58E-06 | 13 | Q16539, P31751, P42338, Q14145, P14598, P10599, P14780, P01375, P04637, P14778, P27930, P0DP23, P08238 | MAPK14, AKT2, PIK3CB, KEAP1, NCF1, TXN, MMP9, TNF, TP53, IL1R1, IL1R2, CALM1, HSP90AB1 | More | | |